Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vascular Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 798 articles:
HTML format



Single Articles


    August 2022
  1. VETROVEC GW
    Robotic coronary angiography: Advantages of stepping back.
    Catheter Cardiovasc Interv. 2022;100:214-215.
    PubMed    


  2. DI MARIO C, Kucukseymen S
    Second generation drug eluting stent: The longer, the better?
    Catheter Cardiovasc Interv. 2022;100:188-189.
    PubMed    


  3. MOUSLY H, Hajjari J, Chami T, Hammad T, et al
    Percutaneous mechanical thrombectomy and extracorporeal membranous oxygenation: A case series.
    Catheter Cardiovasc Interv. 2022;100:274-278.
    PubMed     Abstract available


  4. GAUTIER A, Hovasse T, Arroyo D, Unterseeh T, et al
    Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
    Catheter Cardiovasc Interv. 2022;100:179-187.
    PubMed     Abstract available


    July 2022
  5. SHELDON M, Blankenship JC
    STEMI in nonagenarians: Never too old.
    Catheter Cardiovasc Interv. 2022;100:17-18.
    PubMed    


  6. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    PubMed    


  7. DI SERAFINO L, Esposito G
    May FFR-guided PCI save lives?: Commentary on: "Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry".
    Catheter Cardiovasc Interv. 2022;100:49-50.
    PubMed    


  8. KALYANASUNDARAM A, Seth A
    Retrograde CTO PCI-the final frontier-challenges and outcomes.
    Catheter Cardiovasc Interv. 2022;100:28-29.
    PubMed    


  9. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    PubMed    


  10. ADJEDJ J, Morelle JF, Saint Etienne C, Fichaux O, et al
    Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry.
    Catheter Cardiovasc Interv. 2022;100:40-48.
    PubMed     Abstract available


  11. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    PubMed     Abstract available


    June 2022
  12. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    PubMed     Abstract available


  13. SIMSEK B, Brilakis ES
    Why double-kissing crush should be preferred over culotte for two-stent bifurcation stenting.
    Catheter Cardiovasc Interv. 2022;99:2006-2007.
    PubMed    


  14. SETO AH
    Closing the loop in cath lab communication: Avoiding the tower of babble.
    Catheter Cardiovasc Interv. 2022;99:1963-1964.
    PubMed    


  15. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    PubMed     Abstract available


  16. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2022;99:1965-1975.
    PubMed     Abstract available


  17. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    PubMed     Abstract available


    May 2022
  18. JOSEPH T, VanOosterhout S, Negash A, VanLoo L, et al
    Robotically performed diagnostic coronary angiography.
    Catheter Cardiovasc Interv. 2022 May 27. doi: 10.1002/ccd.30250.
    PubMed     Abstract available


  19. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    PubMed     Abstract available


  20. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    PubMed     Abstract available


  21. ISMAYL M, Machanahalli Balakrishna A, Walters RW, Pajjuru VS, et al
    In-hospital mortality and readmission after ST-elevation myocardial infarction in nonagenarians: A nationwide analysis from the United States.
    Catheter Cardiovasc Interv. 2022 May 14. doi: 10.1002/ccd.30227.
    PubMed     Abstract available


  22. VAN HATTEM VAE, Otterspoor LC, Lipsic E, Vlaar PJJ, et al
    Right ventricular hematoma: A rare but potentially fatal complication of percutaneous coronary artery intervention.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30226.
    PubMed     Abstract available


  23. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    PubMed     Abstract available


  24. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    PubMed     Abstract available


  25. MA W, Wang Q, Wang B, Wang C, et al
    Novel predictors of stent under-expansion regarding calcified coronary lesions assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1473-1481.
    PubMed     Abstract available


  26. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    PubMed     Abstract available


  27. HE J, Zhang D, Zhang R, Wang H, et al
    Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system in unprotected left main bifurcation.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1465-1472.
    PubMed     Abstract available


  28. GUAN C, Geng L, Zhang R, You J, et al
    Long-term prognostic value of dynamic function assessment of intermediate coronary lesion with computational physiology.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1386-1394.
    PubMed     Abstract available


  29. LEE A, Kimmelstiel C
    Stretching and cutting after drilling. Vessel preparation following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022;99:1750-1751.
    PubMed    


  30. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    PubMed     Abstract available


  31. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    PubMed     Abstract available


  32. DALEN M, Settergren M, Kastengren M, Ullstrom P, et al
    Percutaneous decannulation of extracorporeal membrane oxygenation using a plug-based closure device.
    Catheter Cardiovasc Interv. 2022;99:1945-1952.
    PubMed     Abstract available


    April 2022
  33. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    PubMed     Abstract available


  34. MOTIWALA A, Jneid H
    Reflections on the association of thrombocytopenia with adverse outcomes after PCI.
    Catheter Cardiovasc Interv. 2022;99:1498-1499.
    PubMed    


  35. FABRIS E, Menzio S, Gregorio C, Pezzato A, et al
    Effect of prehospital treatment in STEMI patients undergoing primary PCI.
    Catheter Cardiovasc Interv. 2022;99:1500-1508.
    PubMed     Abstract available


  36. GROOT JEBBINK E, van Wijck I, Holewijn S, Iida O, et al
    Individual patient data meta-analysis of patients treated with a heparin-bonded Viabahn in the femoropopliteal artery for chronic limb-threatening ischemia.
    Catheter Cardiovasc Interv. 2022;99:1714-1722.
    PubMed     Abstract available


  37. RIVERO F, Marco V, Biccire FG, Budassi S, et al
    The double injection technique to improve visualization of severe coronary lesions with optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99:1511-1517.
    PubMed     Abstract available


  38. SONCK J, Mizukami T, Johnson NP, Nagumo S, et al
    Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks.
    Catheter Cardiovasc Interv. 2022;99:1518-1525.
    PubMed     Abstract available


  39. KHOKHAR AA, Zelias A, Zlahoda-Huzior A, Dudek D, et al
    Complication during robotic-PCI: Iatrogenic guiding catheter dissection.
    Catheter Cardiovasc Interv. 2022;99:1526-1528.
    PubMed     Abstract available


    March 2022
  40. SIMSEK B, Kostantinis S, Karacsonyi J, Hall A, et al
    International percutaneous coronary intervention complication survey.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30173.
    PubMed     Abstract available


  41. SUMMERS MR, Lavigne PM, Mahoney PD
    Completion peripheral angiography in single-access, Impella-assisted, high-risk PCI: Using a buddy microcatheter sheath after MANTA closure for imaging and potential bailout.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30145.
    PubMed     Abstract available


  42. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    PubMed     Abstract available


  43. SANZ-SANCHEZ J, Mashayekhi K, Agostoni P, Egred M, et al
    Device entrapment during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30160.
    PubMed     Abstract available


  44. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    PubMed     Abstract available


  45. TARANTINI G, Cardaioli F
    Bioresorbable scaffolds: zebras are not striped horses.
    Catheter Cardiovasc Interv. 2022;99:1084-1085.
    PubMed    


  46. WINSCOTT JG, Hillegass WB
    Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART).
    Catheter Cardiovasc Interv. 2022;99:1317-1318.
    PubMed    


  47. PATEL NJ, Heuser RR
    Physiologic liquid plumber: A novel treatment to facilitate crossing of chronic total occlusions.
    Catheter Cardiovasc Interv. 2022;99:1074.
    PubMed    


  48. DROSOU ME, Gray WA
    Clipping costs.
    Catheter Cardiovasc Interv. 2022;99:1257-1258.
    PubMed    


  49. GRINES CL, Marshall JJ
    Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease.
    Catheter Cardiovasc Interv. 2022;99:968-969.
    PubMed    


  50. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    PubMed    


  51. DANGAS G, Garg A
    Double kissing crush stenting: No pain, no gain?
    Catheter Cardiovasc Interv. 2022;99:1045-1046.
    PubMed    


  52. SIMSEK B, Kostantinis S, Karacsonyi J, Vemmou E, et al
    Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;99:1038-1044.
    PubMed     Abstract available


  53. BISCAGLIA S, Erriquez A, Serenelli M, D'Ascenzo F, et al
    Complete versus culprit-only strategy in older MI patients with multivessel disease.
    Catheter Cardiovasc Interv. 2022;99:970-978.
    PubMed     Abstract available


  54. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    PubMed     Abstract available


  55. KARIM AM, Li J, Panhwar MS, Arshad S, et al
    Impact of malnutrition and frailty on mortality and major amputation in patients with CLTI.
    Catheter Cardiovasc Interv. 2022;99:1300-1309.
    PubMed     Abstract available


  56. TOMA C, Bunte MC, Cho KH, Jaber WA, et al
    Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry.
    Catheter Cardiovasc Interv. 2022;99:1345-1355.
    PubMed     Abstract available


  57. TAKAHASHI T, Nishi T, Zimmermann FM, Granada JF, et al
    Clinical validation of a novel simplified offline tool for SYNTAX score calculation.
    Catheter Cardiovasc Interv. 2022;99:1366-1368.
    PubMed    


  58. GRAHAM JJ, Bagai A, Wijeysundera H, Weisz G, et al
    Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial.
    Catheter Cardiovasc Interv. 2022;99:1065-1073.
    PubMed     Abstract available


  59. SINGH N, Ding L, Magee GA, Shavelle DM, et al
    Contemporary treatment of below-the-knee peripheral arterial disease in patients with chronic limb threatening ischemia: Observations from the Vascular Quality Initiative.
    Catheter Cardiovasc Interv. 2022;99:1289-1299.
    PubMed     Abstract available


  60. NAN TIE E, Fernando H, Nehme Z, Dinh D, et al
    Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes.
    Catheter Cardiovasc Interv. 2022;99:989-995.
    PubMed     Abstract available


  61. ULLAH W, Zghouzi M, Sattar Z, Ahmad B, et al
    Safety and efficacy of drug-coated balloon for peripheral artery revascularization-A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1319-1326.
    PubMed     Abstract available


  62. HANSEN KN, Maeng M, Raungaard B, Engstrom T, et al
    Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
    Catheter Cardiovasc Interv. 2022;99:1095-1103.
    PubMed     Abstract available


  63. PARK JH, Rha SW
    Early-onset persistent type IIIb endoleak following incraft stent graft implantation in an abdominal aortic aneurysm patient.
    Catheter Cardiovasc Interv. 2022;99:1358-1362.
    PubMed     Abstract available


  64. BARKHOLT TO, Neghabat O, Holck EN, Andreasen LN, et al
    Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Catheter Cardiovasc Interv. 2022;99:1075-1083.
    PubMed     Abstract available


  65. WILLIAMS T, Mittal A, Karageorgiev D, Iniguez Romo A, et al
    Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry.
    Catheter Cardiovasc Interv. 2022;99:961-967.
    PubMed     Abstract available


  66. CIOPPA A, Franzese M, Gerardi D, Pucciarelli A, et al
    Three-year outcome of directional atherectomy and drug coated balloon for the treatment of common femoral artery steno-occlusive lesions.
    Catheter Cardiovasc Interv. 2022;99:1310-1316.
    PubMed     Abstract available


  67. PRASAD A, Amin AP, Ryan MP, Gunnarsson C, et al
    Use of iso-osmolar contrast media during endovascular revascularization is associated with a lower incidence of major adverse renal, cardiac, or limb events.
    Catheter Cardiovasc Interv. 2022;99:1335-1342.
    PubMed     Abstract available


    February 2022
  68. ARCHILLETTI F, Giuliani L, Dangas GD, Ricci F, et al
    Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Feb 19. doi: 10.1002/ccd.30137.
    PubMed     Abstract available


  69. HANNA EB, Rossen J, Eustes AS, Dayal S, et al
    Heavy lone coronary artery thrombosis treated by stent retriever, in the setting of COVID-19 infection.
    Catheter Cardiovasc Interv. 2022;99:457-461.
    PubMed     Abstract available


  70. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    PubMed     Abstract available


  71. ALASNAG M
    Sound and light editorial: The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2022;99:674-675.
    PubMed    


  72. TEHRANI DM, Seto AH
    Clinical risk overlaps both bare metal and drug-eluting stents.
    Catheter Cardiovasc Interv. 2022;99:552-553.
    PubMed    


  73. VARBELLA F, Cerrato E, Rolfo C, Quadri G, et al
    Characteristics and outcomes of elderly patients undergoing carotid stenting: Experience of a high-volume interventional cardiology center.
    Catheter Cardiovasc Interv. 2022;99:853-859.
    PubMed     Abstract available


  74. TARANTINI G, Cardaioli F
    Coronary complete revascularization strategy: A puzzle still hard to complete.
    Catheter Cardiovasc Interv. 2022;99:639-640.
    PubMed    


  75. GOLDSTEIN JA, Mehta NK
    Extent of coronary atherosclerosis and ischemic myocardium foment sudden cardiac death.
    Catheter Cardiovasc Interv. 2022;99:812-813.
    PubMed    


  76. LOW RJB, Khoo DZL, Ong PJL
    Case report: A novel application of the MicroVascular Plug (MVP) in treating distal coronary perforation.
    Catheter Cardiovasc Interv. 2022;99:502-507.
    PubMed     Abstract available


  77. HIDALGO F, Gonzalez-Manzanares R, Ojeda S, Benito-Gonzalez T, et al
    Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
    Catheter Cardiovasc Interv. 2022;99:489-496.
    PubMed     Abstract available


  78. XU R, Shi Y, Chang S, Qin Q, et al
    Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2022;99:226-233.
    PubMed     Abstract available


  79. LEE K, Lee PH, Lee SW, Kwon O, et al
    Primary versus rescue retrograde approach for chronic total coronary occlusion.
    Catheter Cardiovasc Interv. 2022;99:219-225.
    PubMed     Abstract available


  80. PACCHIONI A, Mugnolo A, Sanz Sanchez J, Sgueglia GA, et al
    Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients.
    Catheter Cardiovasc Interv. 2022;99:827-835.
    PubMed     Abstract available


  81. BOCCHINO PP, Franchin L, Angelini F, D'Ascenzo F, et al
    Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis.
    Catheter Cardiovasc Interv. 2022;99:472-479.
    PubMed     Abstract available


  82. KANDZARI DE, Alaswad K, Jaffer FA, Brilakis E, et al
    Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
    Catheter Cardiovasc Interv. 2022;99:263-270.
    PubMed     Abstract available


  83. COUGHLAN JJ, Aytekin A, Koch T, Wiebe J, et al
    Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap.
    Catheter Cardiovasc Interv. 2022;99:541-551.
    PubMed     Abstract available


  84. KANDZARI DE, Kirtane AJ, Mehran R, Price MJ, et al
    Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Catheter Cardiovasc Interv. 2022;99:583-592.
    PubMed     Abstract available


  85. WIEBE J, Hofmann FJ, West N, Baumbach A, et al
    Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
    Catheter Cardiovasc Interv. 2022;99:533-540.
    PubMed     Abstract available


  86. NOGIC J, Nerlekar N, Soon K, Freeman M, et al
    Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry.
    Catheter Cardiovasc Interv. 2022;99:554-562.
    PubMed     Abstract available


  87. ERBEN Y, Meschia JF, Heck DV, Shawl FA, et al
    Safety of the transradial approach to carotid stenting.
    Catheter Cardiovasc Interv. 2022;99:814-821.
    PubMed     Abstract available


  88. EBERLI FR, Stoll HP, Urban P, Morice MC, et al
    Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
    Catheter Cardiovasc Interv. 2022;99:593-600.
    PubMed     Abstract available


  89. HUSSAIN Y, Gaston S, Kluger J, Shah T, et al
    Long term outcomes of ultrathin versus standard thickness second-generation drug eluting stents: Meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2022;99:563-574.
    PubMed     Abstract available


  90. HAKEEM A, Hou L, Shah K, Agarwal SK, et al
    Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry.
    Catheter Cardiovasc Interv. 2022;99:714-722.
    PubMed     Abstract available


  91. NOIRCLERC N, Marliere S, Bakhti A, Mangin L, et al
    Impact of a micro-net mesh technology covering stent on coronary microvascular dysfunction in patients with high thrombus burden.
    Catheter Cardiovasc Interv. 2022;99:397-404.
    PubMed     Abstract available


  92. SCARSINI R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, et al
    Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
    Catheter Cardiovasc Interv. 2022;99:329-339.
    PubMed     Abstract available


  93. KARMPALIOTIS D, Stoler R, Walsh S, El-Jack S, et al
    Safety and efficacy of Everolimus-Eluting bioabsorbable Polymer-Coated stent in patients with long coronary lesions: The EVOLVE 48 study.
    Catheter Cardiovasc Interv. 2022;99:373-380.
    PubMed     Abstract available


  94. ZAFIROVSKA B, Jovkovski A, Vasilev I, Taravari H, et al
    Ipsilateral transulnar artery approach catheterizations after failure of the radial approach-Are two sheaths in the same arm safe?
    Catheter Cardiovasc Interv. 2022;99:411-417.
    PubMed     Abstract available


  95. OSMAN M, Ghaffar YA, Osman K, Kheiri B, et al
    Gender-based outcomes of coronary bifurcation stenting: A report from the National Readmission Database.
    Catheter Cardiovasc Interv. 2022;99:433-439.
    PubMed     Abstract available


  96. VAN HEMERT ND, Rozemeijer R, Voskuil M, Stein M, et al
    Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    Catheter Cardiovasc Interv. 2022;99:366-372.
    PubMed     Abstract available


  97. IQBAL MB, Moore PT, Nadra IJ, Robinson SD, et al
    Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2022;99:627-638.
    PubMed     Abstract available


  98. ANCHAN R, Venturini J, Larsen P, Lee L, et al
    Safe and rapid radial hemostasis achieved using a novel topical hemostatic patch: Results of a first-in-human pilot study using hydrophobically modified polysaccharide-chitosan.
    Catheter Cardiovasc Interv. 2022;99:786-794.
    PubMed     Abstract available


  99. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    PubMed     Abstract available


  100. SAITO Y, Wijns W, Baumbach A, Xu B, et al
    Differential impact of abluminal groove-filled biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent on and off dual antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;99:357-365.
    PubMed     Abstract available


    January 2022
  101. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    PubMed     Abstract available


  102. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    PubMed     Abstract available


  103. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    PubMed     Abstract available


  104. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    PubMed     Abstract available


  105. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    PubMed     Abstract available


  106. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    PubMed     Abstract available


  107. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    PubMed     Abstract available


  108. LI W, Takahashi T, Rios SA, Latib A, et al
    Diagnostic performance and prognostic impact of coronary angiography-based Index of Microcirculatory Resistance assessment: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30076.
    PubMed     Abstract available


  109. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    PubMed     Abstract available


  110. SIMSEK B, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention in prior coronary artery bypass graft surgery patients: Caveat Emptor!
    Catheter Cardiovasc Interv. 2022;99:85-87.
    PubMed    


  111. LI J, Arora S, Ikeoka K, Smith J, et al
    The utility of geriatric nutritional risk index to predict outcomes in chronic limb-threatening ischemia.
    Catheter Cardiovasc Interv. 2022;99:121-133.
    PubMed     Abstract available


  112. IMPROTA R, Scarparo P, Wilschut J, Wolff Q, et al
    Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.
    Catheter Cardiovasc Interv. 2022;99:88-97.
    PubMed     Abstract available


  113. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;99:98-113.
    PubMed     Abstract available


  114. VEMMOU E, Nikolakopoulos I, Xenogiannis I, Karacsonyi J, et al
    Learning and innovation among interventional cardiologists: Insights from an international survey.
    Catheter Cardiovasc Interv. 2022;99:11-16.
    PubMed     Abstract available


  115. NAVARESE EP, Kandzari DE
    REPLY: ITT (intrepret and test to effectively treat) approach for no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E44-E45.
    PubMed    


  116. MOVAHED MR
    Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E43.
    PubMed    


    December 2021
  117. DEMIR OM, Little CD, Jabbour R, Rahman H, et al
    Impact of COVID-19 pandemic on the management of nonculprit lesions in patients presenting with ST-elevation myocardial infarction: Outcomes from the pan-London heart attack centers.
    Catheter Cardiovasc Interv. 2021 Dec 30. doi: 10.1002/ccd.30056.
    PubMed     Abstract available


  118. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2021 Dec 28. doi: 10.1002/ccd.30049.
    PubMed     Abstract available


  119. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    PubMed     Abstract available


  120. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    PubMed     Abstract available


  121. KORNOWSKI R
    Left main coronary revascularization strategies in the COVID-19 era.
    Catheter Cardiovasc Interv. 2021;98:1262-1263.
    PubMed    


  122. VETROVEC GW
    Surgical turndowns are not no option patients.
    Catheter Cardiovasc Interv. 2021;98:1230-1231.
    PubMed    


  123. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    PubMed    


  124. KUMAR A, Jneid H
    Predicting mortality after percutaneous coronary intervention: The need for improved risk models.
    Catheter Cardiovasc Interv. 2021;98:1298-1299.
    PubMed    


  125. SHUNK KA
    The CathPCI Registry (still) welcomes ambulatory surgical center participation.
    Catheter Cardiovasc Interv. 2021;98:1415.
    PubMed    


  126. RAO S, Karuppasamy K, Radhakrishnan K, Fagan TE, et al
    Restriction of congenital portosystemic shunt using the modified microvascular plug.
    Catheter Cardiovasc Interv. 2021;98:1358-1362.
    PubMed     Abstract available


  127. KLEIN LW, Tamis-Holland J, Kirtane AJ, Anderson HV, et al
    The appropriate use criteria: Improvements for its integration into real world clinical practice.
    Catheter Cardiovasc Interv. 2021;98:1349-1357.
    PubMed     Abstract available


  128. CHICHAREON P, van Klaveren D, Modolo R, Kogame N, et al
    Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
    Catheter Cardiovasc Interv. 2021;98:1287-1297.
    PubMed     Abstract available


  129. VERDOIA M, Rolla R, Pergolini P, Gioscia R, et al
    Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Catheter Cardiovasc Interv. 2021;98:1309-1316.
    PubMed     Abstract available


  130. ABHYANKAR A, Abizaid A, Chamie D, Patel G, et al
    Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:1335-1342.
    PubMed     Abstract available


  131. OJEDA S, Azzalini L, Suarez de Lezo J, Johal GS, et al
    Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1241-1249.
    PubMed     Abstract available


  132. KOUTOUZIS M, Liontou C, Xenogiannis I, Tajti P, et al
    Same day discharge after chronic total occlusion interventions: A single center experience.
    Catheter Cardiovasc Interv. 2021;98:1232-1239.
    PubMed     Abstract available


    November 2021
  133. BHARDWAJ B, Gunzburger E, Valle JA, Grunwald GK, et al
    Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.
    Catheter Cardiovasc Interv. 2021 Nov 30. doi: 10.1002/ccd.30024.
    PubMed     Abstract available


  134. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    PubMed     Abstract available


  135. AKL E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, et al
    First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30001.
    PubMed     Abstract available


  136. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    PubMed     Abstract available


  137. VALLURUPALLI S, Salehi N, Agarwal S, Hasan R, et al
    Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention.
    Catheter Cardiovasc Interv. 2021;98:1021-1026.
    PubMed     Abstract available


  138. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    PubMed    


  139. MEHTA S, Grines CL, Botelho R, Fernandez F, et al
    STEMI telemedicine for 100 million lives.
    Catheter Cardiovasc Interv. 2021;98:1066-1071.
    PubMed     Abstract available


  140. PIAYDA K, Grunwald I, Sievert K, Bertog S, et al
    Acute stroke intervention for acute embolic procedural strokes performed by cardiologists.
    Catheter Cardiovasc Interv. 2021;98:E963-E967.
    PubMed     Abstract available


  141. MARMAGKIOLIS K, Caballero JA, Cilingiroglu M, Iliescu C, et al
    Single-access dual-injection technique (SADIT) for high-risk PCI with Impella CP.
    Catheter Cardiovasc Interv. 2021;98:1138-1140.
    PubMed     Abstract available


  142. ROY S, Choxi R, Wasilewski M, Jovin IS, et al
    Novel oral anticoagulants in the treatment of radial artery occlusion.
    Catheter Cardiovasc Interv. 2021;98:1133-1137.
    PubMed     Abstract available


  143. CERRATO E, Belliggiano D, Quadri G, Erriquez A, et al
    Anatomical and functional healing after resorbable magnesium scaffold implantation in human coronary vessels: A combined optical coherence tomography and quantitative flow ratio analysis.
    Catheter Cardiovasc Interv. 2021;98:1038-1046.
    PubMed     Abstract available


  144. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Karacsonyi J, et al
    Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 14. doi: 10.1002/ccd.30010.
    PubMed     Abstract available


  145. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    PubMed    


  146. KIRRESH A, Candilio L, Stone GW
    Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30008.
    PubMed     Abstract available


  147. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    PubMed     Abstract available


  148. KALETA FP, Gilchrist IC
    PRECISE-DAPT: A tool to measure if Afib patients may risk being stretched too thin.
    Catheter Cardiovasc Interv. 2021;98:846-847.
    PubMed    


  149. TOELG R, Slagboom T, Waltenberger J, Lefevre T, et al
    Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
    Catheter Cardiovasc Interv. 2021;98:848-856.
    PubMed     Abstract available


  150. FUJIHARA M, Takahara M, Yamaoka T, Iida O, et al
    Clinical outcomes of endovascular procedure using VIABAHN(R) VBX covered stent in complex aortoiliac artery disease: Result from AVOCADO study.
    Catheter Cardiovasc Interv. 2021;98:928-937.
    PubMed     Abstract available


  151. NOGUCHI M, Dohi T, Okazaki S, Matsumura M, et al
    Comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:E677-E686.
    PubMed     Abstract available


  152. ZANCA F, Dabin J, Collard C, Alexandre N, et al
    Evaluation of a suspended radiation protection system to reduce operator exposure in cardiology interventional procedures.
    Catheter Cardiovasc Interv. 2021;98:E687-E694.
    PubMed     Abstract available


  153. FAGEL ND, Amoroso G, Rabbering T, Gescher F, et al
    One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
    Catheter Cardiovasc Interv. 2021;98:E661-E667.
    PubMed     Abstract available


  154. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    PubMed     Abstract available


  155. HERNANDEZ-ENRIQUEZ M, Belle L, Madiot H, Pansieri M, et al
    Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry.
    Catheter Cardiovasc Interv. 2021;98:874-881.
    PubMed     Abstract available


  156. SALINAS P, Sanchez-Casanueva RM, Gonzalo N, A Gil J, et al
    Dose-reducing fluoroscopic system decreases patient but not occupational radiation exposure in chronic total occlusion intervention.
    Catheter Cardiovasc Interv. 2021;98:895-902.
    PubMed     Abstract available


  157. D'ASCENZO F, Saglietto A, Ramakrishna H, Andreis A, et al
    Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry.
    Catheter Cardiovasc Interv. 2021;98:864-871.
    PubMed     Abstract available


  158. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    PubMed     Abstract available


    October 2021
  159. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    PubMed     Abstract available


  160. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    PubMed     Abstract available


  161. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    PubMed     Abstract available


  162. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    PubMed    


  163. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    PubMed     Abstract available


  164. ZGHOUZI M, Moussa Pacha H, Ullah W, Sattar Y, et al
    In-hospital outcomes of endovascular versus surgical revascularization for chronic total occlusion in peripheral artery disease.
    Catheter Cardiovasc Interv. 2021;98:E586-E593.
    PubMed     Abstract available


  165. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    PubMed     Abstract available


  166. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed     Abstract available


  167. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    PubMed     Abstract available


  168. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed     Abstract available


  169. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    PubMed     Abstract available


  170. YELAVARTHY P, Seth M, Pielsticker E, Grines CL, et al
    The DISCO study-Does Interventionalists' Sex impact Coronary Outcomes?
    Catheter Cardiovasc Interv. 2021;98:E531-E539.
    PubMed     Abstract available


  171. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    PubMed     Abstract available


  172. RAMASAMY A, Bajaj R, Jones DA, Amersey R, et al
    Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years.
    Catheter Cardiovasc Interv. 2021;98:649-655.
    PubMed     Abstract available


  173. MIDULLA M, Chevallier O, Comby PO, Giordano G, et al
    Endovascular management of the deep venous thrombosis: A new challenging role for the endovascular specialist in 2020.
    Catheter Cardiovasc Interv. 2021;98:748-755.
    PubMed     Abstract available


  174. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    PubMed     Abstract available


  175. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    PubMed     Abstract available


  176. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed     Abstract available


  177. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    PubMed     Abstract available


    September 2021
  178. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    PubMed     Abstract available


  179. SOOMRO AY, Almaddah N, Lendel V, Agarwal SK, et al
    Elective percutaneous coronary intervention performed during contrast-induced hypotension.
    Catheter Cardiovasc Interv. 2021 Sep 22. doi: 10.1002/ccd.29958.
    PubMed     Abstract available


  180. WATANABE Y, Mitomo S, Naganuma T, Chieffo A, et al
    The importance of proximal optimization technique with intravascular imaging guided for stenting unprotected left main distal bifurcation lesions: The Milan and New-Tokyo registry.
    Catheter Cardiovasc Interv. 2021 Sep 14. doi: 10.1002/ccd.29954.
    PubMed     Abstract available


  181. ULLAH W, Zghouzi M, Ahmad B, Suleiman AM, et al
    Safety and efficacy of the polymer-free and polymer-coated drug-eluting stents in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Sep 12. doi: 10.1002/ccd.29953.
    PubMed     Abstract available


  182. SHEIBAN I, Ge Z, Kan J, Nie S, et al
    Association of peri-procedural myocardial infarction with mortality after stenting true coronary bifurcation lesions: A pooled individual participant data analysis from four randomized controlled trials.
    Catheter Cardiovasc Interv. 2021 Sep 7. doi: 10.1002/ccd.29946.
    PubMed     Abstract available


  183. BEERKENS FJ, Singh R, Cao D, Claessen BE, et al
    Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
    Catheter Cardiovasc Interv. 2021 Sep 3. doi: 10.1002/ccd.29935.
    PubMed     Abstract available


  184. TARANTINI G, Zuccarelli V
    Percutaneous coronary intervention versus coronary artery bypass graft surgery: The battle rages on.
    Catheter Cardiovasc Interv. 2021;98:434-435.
    PubMed    


  185. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed    


  186. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    PubMed    


  187. STABILE E, Esposito G
    Below the knee percutaneous transluminal angioplasty for claudicants: One vessel is enough to relieve symptoms.
    Catheter Cardiovasc Interv. 2021;98:570-571.
    PubMed     Abstract available


  188. POSTALIAN A, Krajcer Z
    MANTA versus Perclose for large-bore vessel closure: The evidence continues to grow.
    Catheter Cardiovasc Interv. 2021;98:586-587.
    PubMed     Abstract available


  189. COBB H, Spray B, Daily J, Dossey A, et al
    Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patients.
    Catheter Cardiovasc Interv. 2021;98:526-532.
    PubMed     Abstract available


  190. ROCHA-SINGH KJ, Sachar R, DeRubertis BG, Nolte-Ernsting CCA, et al
    Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Catheter Cardiovasc Interv. 2021;98:549-558.
    PubMed     Abstract available


  191. SALAHUDDIN T, Giannopoulos S, Adams G, Armstrong EJ, et al
    Anterior, posterior, or all-vessel infrapopliteal revascularization in patients with moderate-severe claudication: Insights from the LIBERTY 360 study.
    Catheter Cardiovasc Interv. 2021;98:559-569.
    PubMed     Abstract available


  192. KATSUKI T, Yamaji K, Soga Y, Iida O, et al
    New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication.
    Catheter Cardiovasc Interv. 2021;98:E395-E402.
    PubMed     Abstract available


  193. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed     Abstract available


  194. MOCCETTI F, Wolfrum M, Bossard M, Attinger-Toller A, et al
    Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms.
    Catheter Cardiovasc Interv. 2021;98:E462-E465.
    PubMed     Abstract available


  195. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed     Abstract available


  196. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    PubMed     Abstract available


  197. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    PubMed     Abstract available


  198. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    PubMed     Abstract available


  199. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    PubMed     Abstract available


  200. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed     Abstract available


  201. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed     Abstract available


  202. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed     Abstract available


  203. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    PubMed     Abstract available


  204. SHAH R, Labroo A, Davis DA, Le FK, et al
    Increased risk of stent thrombosis with use of a direct oral anticoagulant and a single antiplatelet agent after PCI: A meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:E490-E492.
    PubMed    


  205. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    PubMed     Abstract available


    August 2021
  206. LICHAA H
    Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique.
    Catheter Cardiovasc Interv. 2021 Aug 31. doi: 10.1002/ccd.29940.
    PubMed     Abstract available


  207. YAMADA T, Washimi S, Hashimoto S, Taniguchi N, et al
    Feasibility and safety of the successive use of distal transradial access for coronary angiography and intervention in the same arm.
    Catheter Cardiovasc Interv. 2021 Aug 28. doi: 10.1002/ccd.29938.
    PubMed     Abstract available


  208. SAITO A, Dai Z, Ono M, Kanie T, et al
    The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: A systematic review and meta-regression analysis.
    Catheter Cardiovasc Interv. 2021 Aug 22. doi: 10.1002/ccd.29922.
    PubMed     Abstract available


  209. MATSUOKA T, Kitahara H, Saito K, Mori N, et al
    Utility of near-infrared spectroscopy to detect the extent of lipid core plaque leading to periprocedural myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29927.
    PubMed     Abstract available


  210. YIN T, Zhong X, Tao L, Hu T, et al
    Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29931.
    PubMed     Abstract available


  211. BASIR MB, Lemor A, Gorgis S, Taylor AM, et al
    Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29895.
    PubMed     Abstract available


  212. JIA X, Jneid H
    Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned.
    Catheter Cardiovasc Interv. 2021;98:223-224.
    PubMed    


  213. GARCIA S, Stanberry L, Schmidt C, Sharkey S, et al
    Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
    Catheter Cardiovasc Interv. 2021;98:217-222.
    PubMed     Abstract available


  214. CAO D, Dangas GD
    Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better.
    Catheter Cardiovasc Interv. 2021;98:206-207.
    PubMed    


  215. WINSCOTT JG, Hillegass WB
    Critical limb ischemia in the end stage renal disease patient: Some next steps.
    Catheter Cardiovasc Interv. 2021;98:308-309.
    PubMed    


  216. SHROFF GR, Henry TD
    Percutaneous coronary intervention in end-stage kidney disease: Trapped between a rock and a hard place.
    Catheter Cardiovasc Interv. 2021;98:215-216.
    PubMed    


  217. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed     Abstract available


  218. DAWSON DB, Telles-Garcia NA, Atkins JL, Mina GS, et al
    End-stage renal disease patients undergoing angioplasty and bypass for critical limb ischemia have worse outcomes compared to non-ESRD patients: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:297-307.
    PubMed     Abstract available


  219. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    PubMed     Abstract available


  220. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    PubMed     Abstract available


  221. PATHAN AZ, Aijaz S, Sheikh S, Sattar S, et al
    Randomized trial comparing radial hemostasis techniques; catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band.
    Catheter Cardiovasc Interv. 2021;98:E181-E187.
    PubMed     Abstract available


  222. KABIR R, Vuppala S, Liu Y, Tejani I, et al
    Clinical outcomes of patients with and without chronic kidney disease undergoing endovascular revascularization of infrainguinal peripheral artery disease: Insights from the XLPAD registry.
    Catheter Cardiovasc Interv. 2021;98:310-316.
    PubMed     Abstract available


  223. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    PubMed    


  224. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    PubMed    


  225. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed     Abstract available


  226. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    PubMed     Abstract available


  227. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    PubMed     Abstract available


  228. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    PubMed    


  229. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    PubMed     Abstract available


    July 2021
  230. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    PubMed     Abstract available


  231. SCHUMACHER SP, Everaars H, Stuijfzand WJ, van Diemen PA, et al
    Viability and functional recovery after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 30. doi: 10.1002/ccd.29888.
    PubMed     Abstract available


  232. MARCUSOHN E, Zukermann R, Kerner A, Roguin A, et al
    Long-term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29870.
    PubMed     Abstract available


  233. TAVENIER AH, Claassens DMF, Hermanides RS, Vos GJA, et al
    Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
    Catheter Cardiovasc Interv. 2021 Jul 7. doi: 10.1002/ccd.29861.
    PubMed     Abstract available


  234. HERMILLER JB JR, Gunnarsson CL, Ryan MP, Moore KA, et al
    The need for future coronary access following surgical or transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29841.
    PubMed     Abstract available


  235. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    PubMed    


  236. ICHIHASHI S, Tamura Y, Maeda S, Kichikawa K, et al
    Percutaneous deep venous arterialization at femoropopliteal segment for unhealed amputated stump ulcer after below the knee amputation.
    Catheter Cardiovasc Interv. 2021;98:E124-E126.
    PubMed     Abstract available


  237. SULIMOV DS, Markuske M, Desch S, Thiele H, et al
    Management of dead space thrombosis during decannulation of peripherally inserted venoarterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2021;98:E122-E123.
    PubMed     Abstract available


  238. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    PubMed     Abstract available


  239. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed     Abstract available


  240. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    PubMed     Abstract available


  241. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed     Abstract available


  242. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    PubMed     Abstract available


  243. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed     Abstract available


  244. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed     Abstract available


  245. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    PubMed     Abstract available


  246. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed     Abstract available


    June 2021
  247. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed     Abstract available


  248. SCHUKRAFT S, Arroyo D, Togni M, Goy JJ, et al
    Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29837.
    PubMed     Abstract available


  249. RAHMAN F, Jneid H
    The continuing promise of the radial access for coronary interventions.
    Catheter Cardiovasc Interv. 2021;97:1397-1398.
    PubMed    


  250. NAGARAJA V, Rao SV, George S, Mamas M, et al
    Evidence-based arterial access site practice in patients with acute coronary syndromes: Has SAFARI-STEMI changed the landscape?
    Catheter Cardiovasc Interv. 2021;97:1417-1421.
    PubMed    


  251. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    PubMed     Abstract available


  252. BEN-DOR I, Sharma A, Rogers T, Yerasi C, et al
    Micropuncture technique for femoral access is associated with lower vascular complications compared to standard needle.
    Catheter Cardiovasc Interv. 2021;97:1379-1385.
    PubMed     Abstract available


  253. ANDO G, Capodanno D
    Safe femoral access for STEMI patients and mortality in the new decade: Back to the future?
    Catheter Cardiovasc Interv. 2021;97:E1054-E1056.
    PubMed    


  254. OKSNES A, McEntegart M
    Intravascular lithotripsy in saphenous vein grafts and graft stent failure: A case series.
    Catheter Cardiovasc Interv. 2021;97:E945-E950.
    PubMed     Abstract available


  255. PATEL NJ, Okamoto N, Murphy J, Vengrenyuk Y, et al
    Management of calcified coronary artery bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:1407-1416.
    PubMed     Abstract available


  256. TEHRANI BN, Damluji AA, Sherwood MW, Rosner C, et al
    Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.
    Catheter Cardiovasc Interv. 2021;97:1354-1366.
    PubMed     Abstract available


  257. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    PubMed     Abstract available


  258. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;97:1341-1351.
    PubMed     Abstract available


  259. KARAMASIS GV, Kalogeropoulos AS, Gamma RA, Clesham GJ, et al
    Effects of stent postdilatation during primary PCI for STEMI: Insights from coronary physiology and optical coherence tomography.
    Catheter Cardiovasc Interv. 2021;97:1309-1317.
    PubMed     Abstract available


  260. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    PubMed     Abstract available


    May 2021
  261. LEE KH, Torii S, Oguri M, Miyaji T, et al
    Reduction of door-to-balloon time in patients with ST-elevation myocardial infarction by single-catheter primary percutaneous coronary intervention method.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29797.
    PubMed     Abstract available


  262. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed     Abstract available


  263. O'NEILL BP, Grines C, Moses JW, Ohman EM, et al
    Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29758.
    PubMed     Abstract available


  264. COSGROVE C, Hanratty CG, Hill JM, Mahadevan K, et al
    Intravascular lithotripsy for treatment of calcific coronary lesions in ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29801.
    PubMed     Abstract available


  265. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed     Abstract available


  266. ELIA E, Iannaccone M, D'Ascenzo F, Gallone G, et al
    Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 May 24. doi: 10.1002/ccd.29757.
    PubMed     Abstract available


  267. BALDI C, Silverio A, Esposito L, Di Maio M, et al
    Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia.
    Catheter Cardiovasc Interv. 2021 May 5. doi: 10.1002/ccd.29738.
    PubMed     Abstract available


  268. SHOAIB A, Mohamed M, Curzen N, Ludman P, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29691.
    PubMed     Abstract available


  269. TOPAZ O
    The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI.
    Catheter Cardiovasc Interv. 2021;97:1149-1150.
    PubMed    


  270. SHAH J, Levy MS
    GRACEfully assessing the timeline for noninfarct-related artery intervention in ST-elevation myocardial infarction patients.
    Catheter Cardiovasc Interv. 2021;97:1160-1161.
    PubMed    


  271. SHADMAN S, Heyliger S, Watts C, Aghili N, et al
    Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives.
    Catheter Cardiovasc Interv. 2021;97:1296-1300.
    PubMed     Abstract available


  272. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    PubMed     Abstract available


  273. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    PubMed     Abstract available


  274. ALLAHWALA UK, Nour D, Bhatia K, Ward MR, et al
    Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients.
    Catheter Cardiovasc Interv. 2021;97:E771-E777.
    PubMed     Abstract available


  275. FUKAGAWA T, Mori S, Hirano K
    Feasibility of the novel proximal superficial femoral artery puncture technique to recanalize chronic total occlusions.
    Catheter Cardiovasc Interv. 2021;97:E852-E856.
    PubMed     Abstract available


  276. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:1162-1173.
    PubMed     Abstract available


  277. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    PubMed     Abstract available


  278. TESTI G, Ceccacci T, Maioli F, Grotti S, et al
    Medial-to-lateral plantar loop technique for retrograde transcollateral recanalization of the lateral plantar artery in patients with type 3 plantar arch.
    Catheter Cardiovasc Interv. 2021;97:E842-E846.
    PubMed     Abstract available


  279. ARANZULLA TC, Musumeci G
    Morphological stabilization and regression of carotid plaque following therapy with evolocumab in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;97:E835-E841.
    PubMed     Abstract available


  280. WERNER GS, Yaginuma K, Koch M, Tischer K, et al
    Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention.
    Catheter Cardiovasc Interv. 2021;97:1196-1206.
    PubMed     Abstract available


  281. CHEN S, David SW, Khan ZA, Metzger DC, et al
    One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2021;97:1120-1126.
    PubMed     Abstract available


  282. KIM MC, Bae S, Ahn Y, Sim DS, et al
    Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Catheter Cardiovasc Interv. 2021;97:1151-1159.
    PubMed     Abstract available


  283. PAHUJA M, Ranka S, Chehab O, Mishra T, et al
    Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:1129-1138.
    PubMed     Abstract available


  284. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2021;97:1186-1193.
    PubMed     Abstract available


  285. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
    Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
    Catheter Cardiovasc Interv. 2021;97:1109-1117.
    PubMed     Abstract available


  286. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2021;97:1176-1183.
    PubMed     Abstract available


  287. MEIER D, Fournier S, Masci PG, Eeckhout E, et al
    Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
    Catheter Cardiovasc Interv. 2021;97:1141-1148.
    PubMed     Abstract available


  288. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed     Abstract available


  289. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed     Abstract available


  290. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    PubMed     Abstract available


  291. ZHANG J, Qiu M, Na K, Ma S, et al
    Impact of 6- versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1025-1031.
    PubMed     Abstract available


    April 2021
  292. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed     Abstract available


  293. ABIZAID A, Campos CM, Guimaraes PO, Costa JR Jr, et al
    Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.
    Catheter Cardiovasc Interv. 2021 Apr 27. doi: 10.1002/ccd.29709.
    PubMed     Abstract available


  294. OBA Y, Inohara T, Takahashi M, Fukutomi M, et al
    In-hospital outcomes and usage of embolic protection devices in percutaneous coronary intervention for coronary artery bypass grafts: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2021 Apr 16. doi: 10.1002/ccd.29695.
    PubMed     Abstract available


  295. KIM M, Park KW, Lee HS, Ki YJ, et al
    The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29682.
    PubMed     Abstract available


  296. SHARMA SK, Fuster V, Hofstra L, Kini AS, et al
    Lessons learned from reduced acute cardiovascular events and STEMI during Covid-19.
    Catheter Cardiovasc Interv. 2021;97:850-852.
    PubMed    


  297. LOPEZ JJ, Ebinger JE, Allen S, Yildiz M, et al
    Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge.
    Catheter Cardiovasc Interv. 2021;97:847-849.
    PubMed     Abstract available


  298. QUESADA O, Henry TD
    New generation drug eluting stents: Closing the gap in sex disparity in cardiovascular outcomes in women.
    Catheter Cardiovasc Interv. 2021;97:805-806.
    PubMed    


  299. FARHAD H, Levy MS
    PCI for left main bifurcation stenting: A treatment paradigm at a crossroads?
    Catheter Cardiovasc Interv. 2021;97:786-787.
    PubMed    


  300. NICOLAS J, Mehran R
    Bivalirudin versus heparin in PCI: Is the pendulum swinging again in favor of heparin?
    Catheter Cardiovasc Interv. 2021;97:774-775.
    PubMed    


  301. ASHLEY KE, Hillegass WB
    Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Catheter Cardiovasc Interv. 2021;97:795-796.
    PubMed    


  302. FUKAGAWA T, Hirano K, Mori S, Yamawaki M, et al
    Efficacy of the novel technique HIRANODOME in preventing distal embolization during endovascular treatment of femoropopliteal lesions.
    Catheter Cardiovasc Interv. 2021;97:E697-E703.
    PubMed     Abstract available


  303. VERMA I, Chang EY, Kumar G, Sachdeva R, et al
    Catheter directed embolectomy of right atrial clot in transit-A case series.
    Catheter Cardiovasc Interv. 2021;97:869-873.
    PubMed     Abstract available


  304. CHOI CH, Hall JK, Malaver D, Applegate RJ, et al
    A novel technique for postclosure of large-bore sheaths using two Perclose devices.
    Catheter Cardiovasc Interv. 2021;97:905-909.
    PubMed     Abstract available


  305. MENDELSOHN FO, Holmes DR Jr, Hopkins LN
    Expanding the stroke team to include interventional cardiology.
    Catheter Cardiovasc Interv. 2021;97:874-875.
    PubMed     Abstract available


  306. OSMAN M, Syed M, Abdul Ghaffar Y, Patel B, et al
    Gender-based outcomes of impeller pumps percutaneous ventricular assist devices.
    Catheter Cardiovasc Interv. 2021;97:E627-E635.
    PubMed     Abstract available


  307. MODINE T, Vincent F, Delhaye C, Van Belle E, et al
    A dedicated Y-shaped percutaneous ECMO cannula for femoral 2-in-1 vascular access during high-risk procedures.
    Catheter Cardiovasc Interv. 2021;97:959-961.
    PubMed     Abstract available


  308. PROTTY MB, Hussain HI, Gallagher S, Al-Raisi S, et al
    Excimer laser coronary atherectomy during complex PCI: An analysis of 1,471 laser cases from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E653-E660.
    PubMed     Abstract available


  309. LEE CH, Ahn JM, Kang DY, Han M, et al
    Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:776-785.
    PubMed     Abstract available


  310. SHAIK A, Mosleh W, Dahal K, Pickett C, et al
    The absence of evidence is not the evidence of absence: A case report on the challenges in diagnosing ostial left main stenosis.
    Catheter Cardiovasc Interv. 2021;97:836-840.
    PubMed     Abstract available


  311. KITANI S, Igarashi Y, Tsuchikane E, Nakamura S, et al
    Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry).
    Catheter Cardiovasc Interv. 2021;97:E614-E623.
    PubMed     Abstract available


  312. FABBIOCCHI F, Calligaris G, Bartorelli AL
    Progressive growth of coronary aneurysms after bioresorbable vascular scaffold implantation: Successful treatment with OCT-guided exclusion using covered stents.
    Catheter Cardiovasc Interv. 2021;97:E676-E679.
    PubMed     Abstract available


  313. NAZIR S, Ahuja KR, Virk HUH, Elzanaty A, et al
    A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:788-794.
    PubMed     Abstract available


  314. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed     Abstract available


    March 2021
  315. LIU ZY, Yin ZH, Liang CY, He J, et al
    Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29655.
    PubMed     Abstract available


  316. MOHAMED MO, Curzen N, de Belder M, Goodwin AT, et al
    Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29663.
    PubMed     Abstract available


  317. HU X, Qiao S, Guan C, Guo C, et al
    Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29651.
    PubMed     Abstract available


  318. SHAH AM, Siddiqui E, Cuenca C, Drotar P, et al
    Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29649.
    PubMed     Abstract available


  319. OTSUKA T, Ueki Y, Kavaliauskaite R, Zanchin T, et al
    Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29650.
    PubMed     Abstract available


  320. WANG H, Wang HY, Yin D, Feng L, et al
    Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29653.
    PubMed     Abstract available


  321. PLOUMEN EH, Buiten RA, Zocca P, Doggen CJM, et al
    Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29594.
    PubMed     Abstract available


  322. GAO L, Gao Z, Song Y, Guan C, et al
    Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29586.
    PubMed     Abstract available


  323. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed     Abstract available


  324. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed     Abstract available


  325. LIU S, Song C, Yin D, Wang Y, et al
    Impact of public health emergency response to COVID-19 on management and outcome for NSTEMI patients in Beijing: A single-center historic control.
    Catheter Cardiovasc Interv. 2021;97:E475-E483.
    PubMed     Abstract available


  326. SMALLING RW
    Pre-transfer/PCI with ticagrelor and heparin administration in STEMI patients may be beneficial but should we do more?
    Catheter Cardiovasc Interv. 2021;97:600-601.
    PubMed    


  327. AGARWAL SK, Uretsky BF
    Is it time for a "functional" hybrid algorithm to optimize interventional results in chronic total occlusion?
    Catheter Cardiovasc Interv. 2021;97:656-657.
    PubMed    


  328. ASHLEY KE, Hillegass WB
    Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment.
    Catheter Cardiovasc Interv. 2021;97:579-580.
    PubMed    


  329. PATEL NJ, Heuser RR
    "PROGRESS is our most important product": Adventures in CTO intervention.
    Catheter Cardiovasc Interv. 2021;97:668-669.
    PubMed    


  330. CASE BC, Satler LF
    The challenges of coronary no-reflow phenomenon.
    Catheter Cardiovasc Interv. 2021;97:612-613.
    PubMed    


  331. AREGULLIN EO, Mohammad Nijres B, Al-Khatib Y, Vettukattil J, et al
    Transcatheter Fontan completion using novel balloon and stent system.
    Catheter Cardiovasc Interv. 2021;97:679-684.
    PubMed     Abstract available


  332. N'DANDU Z, Bonilla J, Yousef GM, White CJ, et al
    Percutaneous deep vein arterialization: An emerging technique for no-option chronic limb-threatening ischemia patients.
    Catheter Cardiovasc Interv. 2021;97:685-690.
    PubMed     Abstract available


  333. MIHATOV N, Secemsky EA, Kereiakes DJ, Steg G, et al
    Utility of the dual antiplatelet therapy score to guide antiplatelet therapy: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;97:569-578.
    PubMed     Abstract available


  334. AL NASEF M, Oslizlok P, Walsh KP
    Percutaneous transcatheter occlusion of left atrioventricular valve in a patient with single ventricle and severe atrioventricular valve regurgitation.
    Catheter Cardiovasc Interv. 2021;97:E510-E513.
    PubMed     Abstract available


  335. ENOMOTO Y, Egashira Y, Iwama T
    What's happening in carotid stent? A case report of prominent plaque protrusion after carotid artery stenting observed on angioscopy.
    Catheter Cardiovasc Interv. 2021;97:E532-E535.
    PubMed     Abstract available


  336. JOSHI FR, Lonborg J, Sadjadieh G, Helqvist S, et al
    The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: Results from the DANAMI-3-PRIMULTI randomized study.
    Catheter Cardiovasc Interv. 2021;97:E467-E474.
    PubMed     Abstract available


  337. NAVARESE EP, Frediani L, Kandzari DE, Caiazzo G, et al
    Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.
    Catheter Cardiovasc Interv. 2021;97:602-611.
    PubMed     Abstract available


  338. LEE SH, Choi KH, Lee JM, Shin D, et al
    Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization.
    Catheter Cardiovasc Interv. 2021;97:E454-E466.
    PubMed     Abstract available


  339. WHITBECK MG, Chambers JW
    Single-access during Impella hemodynamic support utilizing the Railway system.
    Catheter Cardiovasc Interv. 2021;97:675-678.
    PubMed     Abstract available


  340. KAYAERT P, Coeman M, Drieghe B, Bennett J, et al
    iFR uncovers profound but mostly reversible ischemia in CTOs and helps to optimize PCI results.
    Catheter Cardiovasc Interv. 2021;97:646-655.
    PubMed     Abstract available


  341. NAKAJIMA A, Araki M, Kurihara O, Minami Y, et al
    Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:634-645.
    PubMed     Abstract available


    February 2021
  342. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    PubMed     Abstract available


  343. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    PubMed     Abstract available


  344. ROTHSTEIN ES, Welch TD, Andrus BW, Jayne JE, et al
    Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.
    Catheter Cardiovasc Interv. 2021;97:E333-E338.
    PubMed     Abstract available


  345. REILLY JP, Parikh PB
    PCI in TAVR patients: Timing isn't everything.
    Catheter Cardiovasc Interv. 2021;97:540-541.
    PubMed    


  346. RAZZOUK L, Jneid H
    Revascularization in patients with diabetes and chronic total occlusion: The journey or the destination?
    Catheter Cardiovasc Interv. 2021;97:384-385.
    PubMed    


  347. ALQAHTANI F, Osman M, Harris AH, Hohmann SF, et al
    Mortality and functional outcomes of endovascular stroke therapy in the United States.
    Catheter Cardiovasc Interv. 2021;97:470-474.
    PubMed     Abstract available


  348. ZHANG Y, Xiang D, Lu Q, Wu M, et al
    A systematic review and meta-analysis of the performance of flow-diverting stents in the treatment of peripheral and visceral artery aneurysms.
    Catheter Cardiovasc Interv. 2021;97:461-469.
    PubMed     Abstract available


  349. KUMAR A, Sammour Y, Reginauld S, Sato K, et al
    Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv. 2021;97:529-539.
    PubMed     Abstract available


  350. CHIABRANDO JG, Lombardi M, Vescovo GM, Wohlford GF, et al
    Stenting techniques for coronary bifurcation lesions: Evidence from a network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2021;97:E306-E318.
    PubMed     Abstract available


  351. MADDER RD, VanOosterhout S, Parker J, Sconzert K, et al
    Robotic telestenting performance in transcontinental and regional pre-clinical models.
    Catheter Cardiovasc Interv. 2021;97:E327-E332.
    PubMed     Abstract available


  352. YASUMURA K, Benhuri B, Vengrenyuk Y, Petrov A, et al
    Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.
    Catheter Cardiovasc Interv. 2021;97:E280-E287.
    PubMed     Abstract available


  353. OSHEROV AB, Qiang B, Butany J, Wright GA, et al
    A calcified chronic total occlusion preclinical model.
    Catheter Cardiovasc Interv. 2021;97:437-442.
    PubMed     Abstract available


  354. ABHYANKAR A, Abizaid A, Chamie D, Rathod M, et al
    Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.
    Catheter Cardiovasc Interv. 2021;97:423-430.
    PubMed     Abstract available


  355. FLORES-UMANZOR EJ, Cepas-Guillen PL, Vazquez S, Fernandez-Valledor A, et al
    Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes.
    Catheter Cardiovasc Interv. 2021;97:376-383.
    PubMed     Abstract available


  356. SAITO Y, Cristea E, Bouras G, Abizaid A, et al
    Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffold.
    Catheter Cardiovasc Interv. 2021;97:431-436.
    PubMed     Abstract available


  357. YA'QOUB L, Gad M, Saad AM, Elgendy IY, et al
    National trends of utilization and readmission rates with intravascular ultrasound use for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29524.
    PubMed     Abstract available


  358. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    PubMed     Abstract available


  359. KINNAIRD T, Anderson R, Gallagher S, Sharp ASP, et al
    Vascular complications associated with intraaortic balloon pump supported percutaneous coronary intervention (PCI) and clinical outcomes from the British Cardiovascular Intervention Society National PCI Database.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29549.
    PubMed     Abstract available


  360. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.
    PubMed    


  361. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed     Abstract available


  362. CHANGAL K
    Angiography versus fractional flow rate-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29540.
    PubMed    


  363. VAN WIECHEN MP, Kroon H, Hokken TW, Ooms JF, et al
    Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29506.
    PubMed     Abstract available


  364. SHIELDS MC, Ouellette M, Kiefer N, Kohan L, et al
    Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29508.
    PubMed     Abstract available


  365. PICCOLO R, Esposito G
    Percutaneous coronary intervention in patients with COVID-19 and acute coronary syndrome: What if the old normal became the new normal?
    Catheter Cardiovasc Interv. 2021;97:199-200.
    PubMed    


  366. TARANTINI G, Nai Fovino L
    Negative impact of coronavirus on interventional cardiology fellows' training: Let's limit collateral damage of the pandemic.
    Catheter Cardiovasc Interv. 2021;97:206-207.
    PubMed    


  367. GUPTA T, Nazif TM, Vahl TP, Ahmad H, et al
    Impact of the COVID-19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter.
    Catheter Cardiovasc Interv. 2021;97:201-205.
    PubMed     Abstract available


  368. SECCO GG, Tarantini G, Mazzarotto P, Garbo R, et al
    Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience.
    Catheter Cardiovasc Interv. 2021;97:195-198.
    PubMed     Abstract available


  369. KAYANI WT, Jneid H
    Increasing stroke events in patients with ST elevation myocardial infraction and cardiogenic shock: A cause for concern.
    Catheter Cardiovasc Interv. 2021;97:226-227.
    PubMed     Abstract available


  370. AGARWAL SK, Uretsky BF
    Toward a more perfect coronary intervention....
    Catheter Cardiovasc Interv. 2021;97:245-246.
    PubMed    


  371. KERN MJ, Seto AH
    How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al.
    Catheter Cardiovasc Interv. 2021;97:257-258.
    PubMed     Abstract available


  372. BUTMAN SM
    Hybrid revascularization procedures for multivessel disease: 2021.
    Catheter Cardiovasc Interv. 2021;97:265-266.
    PubMed    


  373. CELIK O, Guner A, Kalcik M, Guler A, et al
    The predictive value of CHADS2 score for subclinical cerebral ischemia after carotid artery stenting (from the PREVENT-CAS trial).
    Catheter Cardiovasc Interv. 2021;97:301-309.
    PubMed     Abstract available


  374. BARRETT C, Warsavage T, Kovach C, McGuinn E, et al
    Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program.
    Catheter Cardiovasc Interv. 2021;97:E219-E226.
    PubMed     Abstract available


  375. GALLONE G, D'Ascenzo F, Conrotto F, Costa F, et al
    Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations.
    Catheter Cardiovasc Interv. 2021;97:E227-E236.
    PubMed     Abstract available


  376. TAMARU H, Fujii K, Otsuji S, Takiuchi S, et al
    Short- and mid-term influence of drug-coated stent implantation on structural and functional vascular healing response: An optical coherence tomography and acetylcholine testing study.
    Catheter Cardiovasc Interv. 2021;97:E186-E193.
    PubMed     Abstract available


  377. WATANABE Y, Mitomo S, Naganuma T, Kawamoto H, et al
    Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2021;97:E198-E208.
    PubMed     Abstract available


  378. HUSSAIN HI, Protty MB, Gallagher S, Al-Raisi S, et al
    The impact of coronary perforation in percutaneous interventions involving the left main stem coronary artery in the United Kingdom 2007-2014: Insights from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E179-E185.
    PubMed     Abstract available


  379. SHARMA RK, Poulin MF, Tamez-Aguilar H, Pinto DS, et al
    Post hoc closure of large bore vascular access using the MANTA closure device.
    Catheter Cardiovasc Interv. 2021;97:282-286.
    PubMed     Abstract available


    January 2021
  380. CHIARITO M, Cao D, Nicolas J, Roumeliotis A, et al
    Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021 Jan 28. doi: 10.1002/ccd.29486.
    PubMed     Abstract available


  381. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    PubMed     Abstract available


  382. MCKENZIE A, Zhou C, Svendsen C, Anketell R, et al
    Ability of a novel shock index that incorporates invasive hemodynamics to predict mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Jan 9. doi: 10.1002/ccd.29460.
    PubMed     Abstract available


  383. TARANTINI G, Fraccaro C
    Twilight-specific light cues.
    Catheter Cardiovasc Interv. 2021;97:72-73.
    PubMed     Abstract available


  384. KRAJCER Z, Costello B
    Clinical impact of calcified nodules in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:20-21.
    PubMed     Abstract available


  385. RODRIGUEZ-PAZ E, Heuser R
    "Back to the future: Beta radiation to treat recurrent in-stent restenosis".
    Catheter Cardiovasc Interv. 2021;97:47.
    PubMed     Abstract available


  386. SMITH T, Henry TD
    Spontaneous coronary artery dissection with cardiogenic shock: How frequent is it? How should we treat it?
    Catheter Cardiovasc Interv. 2021;97:78-79.
    PubMed     Abstract available


  387. GRINES CL, Yen A
    Between a rock and a hard place: Orbital atherectomy for under-expanded stents.
    Catheter Cardiovasc Interv. 2021;97:8-9.
    PubMed     Abstract available


  388. CHUGH Y, Brilakis ES
    Intravascular lithotripsy for stent under-expansion: Panacea or Pandora's box?
    Catheter Cardiovasc Interv. 2021;97:30-31.
    PubMed     Abstract available


  389. KERN MJ
    Is stealing still a crime? Comment on left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021;97:105-107.
    PubMed     Abstract available


  390. MAESTAS CM, Blankenship JC
    Interventional economics provide a roadmap to better patient care.
    Catheter Cardiovasc Interv. 2021;97:94-96.
    PubMed     Abstract available


  391. FAN LM, Tong D, Mintz GS, Mamas MA, et al
    Breaking the deadlock of calcified coronary artery lesions: A contemporary review.
    Catheter Cardiovasc Interv. 2021;97:108-120.
    PubMed     Abstract available


  392. DI MARCO A, Anguera I, Nombela-Franco L, Oloriz T, et al
    Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Catheter Cardiovasc Interv. 2021;97:E1-E11.
    PubMed     Abstract available


  393. MCQUILLAN C, Jackson MWP, Brilakis ES, Egred M, et al
    Uncrossable and undilatable lesions-A practical approach to optimizing outcomes in PCI.
    Catheter Cardiovasc Interv. 2021;97:121-126.
    PubMed     Abstract available


  394. BABER U, Chandiramani R, Mehta SR, Sartori S, et al
    Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.
    Catheter Cardiovasc Interv. 2021;97:63-71.
    PubMed     Abstract available


  395. KUME T, Murasato Y, Yamada R, Koyama T, et al
    Effect of proximal balloon edge dilation technique for opening a side branch ostium in repetitive-proximal optimizing technique sequence.
    Catheter Cardiovasc Interv. 2021;97:E12-E18.
    PubMed     Abstract available


  396. CHEN K, Scridon T, Chait R
    Inadvertent aortocoronary arteriovenous fistula after CABG: Systematic review of case reports.
    Catheter Cardiovasc Interv. 2021;97:E19-E25.
    PubMed     Abstract available


  397. AZZALINI L, Alaswad K, Uretsky BF, Agostoni P, et al
    Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2021;97:E40-E50.
    PubMed     Abstract available


  398. LAMELAS P, Padilla L, Abud M, Cigalini I, et al
    In-stent chronic total occlusion angioplasty in the LATAM-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:E34-E39.
    PubMed     Abstract available


  399. MOROFUJI T, Kuramitsu S, Shinozaki T, Jinnouchi H, et al
    Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:10-19.
    PubMed     Abstract available


  400. WIEBE J, Hofmann FJ, Dorr O, Bauer T, et al
    Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.
    Catheter Cardiovasc Interv. 2021;97:56-62.
    PubMed     Abstract available


  401. NEUPANE S, Basir M, Tan C, Sultan A, et al
    Feasibility and safety of orbital atherectomy for the treatment of in-stent restenosis secondary to stent under-expansion.
    Catheter Cardiovasc Interv. 2021;97:2-7.
    PubMed     Abstract available


    December 2020
  402. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    PubMed     Abstract available


  403. BLOOM JE, Dinh DT, Noaman S, Martin C, et al
    Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29436.
    PubMed     Abstract available


  404. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed     Abstract available


  405. TOKUDA T, Mori S, Oba Y, Koshida R, et al
    Comparison of ultrasound-guided versus angiography-guided endovascular treatment for femoropopliteal artery occlusive disease.
    Catheter Cardiovasc Interv. 2020 Dec 12. doi: 10.1002/ccd.29437.
    PubMed     Abstract available


  406. ASIF A, Sezer A, Thoma F, Toma C, et al
    Relationship between predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score and mortality among patients with atrial fibrillation undergoing percutaneous coronary interv
    Catheter Cardiovasc Interv. 2020 Dec 9. doi: 10.1002/ccd.29399.
    PubMed     Abstract available


  407. COCKBURN J, Kemp T, Ludman P, Kinnaird T, et al
    Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly.
    Catheter Cardiovasc Interv. 2020 Dec 6. doi: 10.1002/ccd.29406.
    PubMed     Abstract available


  408. ABIZAID A, Kedev S, Ali RBM, Santoso T, et al
    Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29396.
    PubMed     Abstract available


  409. LAZKANI M, Tripathi B, Dattilo P
    Impact of intracoronary imaging on in-hospital mortality and 30-day readmission rates following percutaneous coronary intervention: A nationwide readmissions database analysis.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29394.
    PubMed     Abstract available


    November 2020
  410. GIFFT K, Omran J, Ghrair F, Allaham H, et al
    Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip).
    Catheter Cardiovasc Interv. 2020 Nov 28. doi: 10.1002/ccd.29404.
    PubMed     Abstract available


  411. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    PubMed     Abstract available


  412. BLUM M, Cao D, Chandiramani R, Goel R, et al
    Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29402.
    PubMed     Abstract available


  413. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    PubMed     Abstract available


  414. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    PubMed     Abstract available


  415. KAWASHIMA H, Hara H, Wang R, Ono M, et al
    Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29383.
    PubMed     Abstract available


  416. SHAH S, Castro-Dominguez Y, Gupta T, Attaran R, et al
    Impact of the COVID-19 pandemic on interventional cardiology training in the United States.
    Catheter Cardiovasc Interv. 2020;96:997-1005.
    PubMed     Abstract available


  417. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  418. POSTALIAN A, Krajcer Z
    Chronic total occlusion percutaneous coronary intervention: The Latin American experience.
    Catheter Cardiovasc Interv. 2020;96:1056-1057.
    PubMed    


    October 2020
  419. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed     Abstract available


  420. SOGA Y, Takahara M, Ito N, Katsuki T, et al
    Clinical impact of intravascular ultrasound-guided balloon angioplasty in patients with chronic limb threatening ischemia for isolated infrapopliteal lesion.
    Catheter Cardiovasc Interv. 2020 Oct 21. doi: 10.1002/ccd.29347.
    PubMed     Abstract available


  421. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    PubMed     Abstract available


  422. SEPULVEDA P, Hameau R, Backhouse C, Charme G, et al
    Mid-term follow-up of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: An experience in Latin America.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29322.
    PubMed     Abstract available


  423. GOEL R, Cao D, Chandiramani R, Roumeliotis A, et al
    Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29314.
    PubMed     Abstract available


  424. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    PubMed     Abstract available


  425. PAJJURU VS, Thandra A, Guddeti RR, Kothapalli SR, et al
    ST-elevation myocardial infarction in nonagenarians: A nationwide analysis of trends and outcomes in the United States.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29313.
    PubMed     Abstract available


  426. COLOMBO A, Laricchia A
    Removing the plaque and implanting a drug-eluting stent: The way to success.
    Catheter Cardiovasc Interv. 2020;96:782-783.
    PubMed    


  427. DANGAS G, Khan AA
    Rolling the rock uphill during left main stenting: The Sisyphus myth in percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2020;96:762-763.
    PubMed    


  428. WHITESIDE HL, Moliterno DJ
    Coronary interventions among patients with hepatic insufficiency: Encouragement to avoid a jaundiced view.
    Catheter Cardiovasc Interv. 2020;96:811-812.
    PubMed    


  429. GRINES CL, Tummala P
    Another nail in the coffin for the use of risk-adjusted mortality after percutaneous coronary intervention as a quality indicator.
    Catheter Cardiovasc Interv. 2020;96:741-742.
    PubMed    


  430. GOLDSTEIN JA, Dixon SR
    Mechanically supported PCI for ischemic cardiomyopathy reawakening of hibernating myocardium.
    Catheter Cardiovasc Interv. 2020;96:771-772.
    PubMed    


    September 2020
  431. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    PubMed     Abstract available


  432. KUNO T, Takagi H, Ando T, Kodaira M, et al
    Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29236.
    PubMed     Abstract available


  433. BENGALURU JAYANNA M, Gray WA
    Applied pharmacology in percutaneous coronary intervention: You can't fight mother nature.
    Catheter Cardiovasc Interv. 2020;96:565-566.
    PubMed     Abstract available


  434. BELARDI JA, Lamelas PM
    Gender disparities in high-risk angioplasty: Still room for improvement.
    Catheter Cardiovasc Interv. 2020;96:545-546.
    PubMed    


  435. MUSUMECI G, Annibali G
    Upstream anticoagulation: Another brick in the wall?
    Catheter Cardiovasc Interv. 2020;96:526-527.
    PubMed    


  436. RODRIGUEZ-PAZ E, Heuser RR
    A new perspective in CTO PCI.
    Catheter Cardiovasc Interv. 2020;96:577.
    PubMed    


  437. JHA A, Ahmed M
    An emerging use of the Swan-Ganz catheter: Pulmonary artery catheter delivered thrombolysis in massive pulmonary embolism.
    Catheter Cardiovasc Interv. 2020;96:728-729.
    PubMed    


  438. LOPERA JE, Jen S
    Superior vena cava filter placement over existing central venous lines: Is line removal necessary?
    Catheter Cardiovasc Interv. 2020;96:651-656.
    PubMed     Abstract available


  439. TANNOUS P, Popescu A, Forbess L, Nugent A, et al
    Transcatheter biventricular conversion in an adult patient with a 1.5 ventricle Glenn palliation and superior vena cava syndrome.
    Catheter Cardiovasc Interv. 2020;96:633-637.
    PubMed     Abstract available


  440. MATHIS C, Romans R, Divekar A
    Variation in the outer diameter of vascular sheaths commonly used in infant cardiac catheterization.
    Catheter Cardiovasc Interv. 2020;96:620-625.
    PubMed     Abstract available


  441. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  442. ARANZULLA TC
    One, two, three ... breakdance and twist.
    Catheter Cardiovasc Interv. 2020;96:601-608.
    PubMed     Abstract available


  443. TOVAR FORERO MN, Van Mieghem NM, Daemen J
    Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
    Catheter Cardiovasc Interv. 2020;96:598-600.
    PubMed     Abstract available


  444. ABU SHARAR H, Helfert S, Vafaie M, Pleger ST, et al
    Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Catheter Cardiovasc Interv. 2020;96:578-585.
    PubMed     Abstract available


  445. KANDZARI DE, Lembo NJ, Carlson HD, Kalynych A, et al
    Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study.
    Catheter Cardiovasc Interv. 2020;96:567-576.
    PubMed     Abstract available


  446. PARR CJ, Sharma R, Arora RC, Singal R, et al
    Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory.
    Catheter Cardiovasc Interv. 2020;96:547-555.
    PubMed     Abstract available


  447. DE ROECK F, Tijskens M, Segers VFM
    Coronary-subclavian steal syndrome, an easily overlooked entity in interventional cardiology.
    Catheter Cardiovasc Interv. 2020;96:614-619.
    PubMed     Abstract available


  448. PROMPHAN W, Han Siang K, Prachasilchai P, Jarutach J, et al
    Feasibility and early outcomes of aortic coarctation treatments with BeGraft Aortic stent.
    Catheter Cardiovasc Interv. 2020;96:E310-E316.
    PubMed     Abstract available


  449. NOAMAN S, Andrianopoulos N, Brennan AL, Dinh D, et al
    Outcomes of cardiogenic shock complicating acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020;96:E257-E267.
    PubMed     Abstract available


  450. GALLONE G, D'Ascenzo F, Boccuzzi G, Cortese B, et al
    Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
    Catheter Cardiovasc Interv. 2020;96:E248-E256.
    PubMed     Abstract available


  451. KOREN O, Abu Rajab Saaida R, Rozner E, Turgeman Y, et al
    Outcomes and safety of concurrent coronary and peripheral catheterization (REVascularization in concomitant PERIpheral artery disease and coronary artery disease REV-PERICAD Study).
    Catheter Cardiovasc Interv. 2020;96:E317-E323.
    PubMed     Abstract available


  452. SONCK J, Collet C, Mizukami T, Vandeloo B, et al
    Motorized fractional flow reserve pullback: Accuracy and reproducibility.
    Catheter Cardiovasc Interv. 2020;96:E230-E237.
    PubMed     Abstract available


  453. HASEGAWA K, Yamamoto W, Nakabayashi S, Otsuji S, et al
    Streamlined reverse wire technique for the treatment of complex bifurcated lesions.
    Catheter Cardiovasc Interv. 2020;96:E287-E291.
    PubMed     Abstract available


  454. RADHOE SP, Schuurman AS, Ligthart JM, Witberg K, et al
    Two decades after coronary radiation therapy: A single center longitudinal clinical study.
    Catheter Cardiovasc Interv. 2020;96:E204-E212.
    PubMed     Abstract available


  455. FEMIA G, Faour A, Assad J, Sharma L, et al
    Comparing the clinical and prognostic impact of proximal versus nonproximal lesions in dominant right coronary artery ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Sep 1. doi: 10.1002/ccd.29245.
    PubMed     Abstract available


    August 2020
  456. D'ENTREMONT MA, Laferriere C, Berube S, Couture EL, et al
    The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
    Catheter Cardiovasc Interv. 2020 Aug 29. doi: 10.1002/ccd.29144.
    PubMed     Abstract available


  457. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    PubMed     Abstract available


  458. BOM MJ, Schumacher SP, Driessen RS, van Diemen PA, et al
    Non-invasive procedural planning using computed tomography-derived fractional flow reserve.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29210.
    PubMed     Abstract available


  459. NAIDU SS, Coylewright M, Hawkins BM, Meraj P, et al
    Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions 2020 think tank.
    Catheter Cardiovasc Interv. 2020 Aug 25. doi: 10.1002/ccd.29197.
    PubMed     Abstract available


  460. SHAH H, Patel S, Solanki S, Wudexi I, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients undergoing percutaneous coronary intervention: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29184.
    PubMed     Abstract available


  461. SAGLIETTO A, D'Ascenzo F, Errigo D, Leonardi S, et al
    Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29192.
    PubMed     Abstract available


  462. TEDESCHI D, Rizzi A, Biscaglia S, Tumscitz C, et al
    Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29179.
    PubMed     Abstract available


  463. LAFONT A, Sinnaeve PR, Cuisset T, Cook S, et al
    Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29159.
    PubMed     Abstract available


  464. POSTALIAN A, Krajcer Z
    Transradial versus transfemoral access: The dispute continues.
    Catheter Cardiovasc Interv. 2020;96:296-297.
    PubMed    


  465. BUTMAN SM
    Radial artery intervention: Facile for you is best for me, too.
    Catheter Cardiovasc Interv. 2020;96:274-275.
    PubMed     Abstract available


  466. ASHLEY KE, Hillegass WB
    Insulin-treated diabetes mellitus: An actionable risk factor and marker after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020;96:309-310.
    PubMed    


  467. CHANDRASEKHAR J, Dangas G, Baber U, Sartori S, et al
    Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI.
    Catheter Cardiovasc Interv. 2020;96:298-308.
    PubMed     Abstract available


  468. BENEDUCE A, Ferrante G, Ielasi A, Pivato CA, et al
    One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).
    Catheter Cardiovasc Interv. 2020;96:255-265.
    PubMed     Abstract available


  469. BAYON J, Santas-Alvarez M, Ocaranza-Sanchez R, Gonzalez-Juanatey C, et al
    Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?
    Catheter Cardiovasc Interv. 2020;96:E174-E176.
    PubMed     Abstract available


  470. XI Y, Chen J, Bi Y, Xie S, et al
    Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Catheter Cardiovasc Interv. 2020;96:E129-E141.
    PubMed     Abstract available


  471. BRIGUORI C, Tamburino C, Jessurun GAJ, Meyer-Gessner M, et al
    Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study.
    Catheter Cardiovasc Interv. 2020;96:E142-E148.
    PubMed     Abstract available


  472. PLOUMEN EH, Buiten RA, Kok MM, Doggen CJM, et al
    Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
    Catheter Cardiovasc Interv. 2020;96:E110-E118.
    PubMed     Abstract available


  473. KWON O, Lee JB, Ahn JM, Kang SJ, et al
    Clinical outcomes of contemporary drug-eluting stents in patients with and without diabetes mellitus: Multigroup propensity-score analysis using data from stent-specific, multicenter, prospective registries.
    Catheter Cardiovasc Interv. 2020;96:243-252.
    PubMed     Abstract available


  474. GEORGE JC, Tabaza L, Janzer S
    Robotic-assisted balloon angioplasty and stent placement with distal embolic protection device for severe carotid artery stenosis in a high-risk surgical patient.
    Catheter Cardiovasc Interv. 2020;96:410-412.
    PubMed     Abstract available


  475. QIU Z, Liu J, Huang R, Liu D, et al
    Incidence, risk, and treatment of binary restenosis after vertebral artery stenting.
    Catheter Cardiovasc Interv. 2020;96:404-409.
    PubMed     Abstract available


  476. YAN C, Wan L, Li L, Li H, et al
    Transfemoral transcatheter puncture of interventricular septum in a swine model: A novel transfemoral-venous access to left ventricle with the assistance of arterio-venous circuit.
    Catheter Cardiovasc Interv. 2020;96:488-496.
    PubMed     Abstract available


  477. BUNCH F, Nair P, Aggarwala G, Dippel E, et al
    A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy.
    Catheter Cardiovasc Interv. 2020;96:393-401.
    PubMed     Abstract available


  478. SIVAKUMAR K, Anantharaj A, Raghuram P, Krishna Kumar R, et al
    First in man study of a new semi-open cell design Zephyr cobalt-chromium stent in large vessels and conduits.
    Catheter Cardiovasc Interv. 2020;96:367-375.
    PubMed     Abstract available


  479. BARBASH IM, Kornowski R, Berkovitch A, Assali A, et al
    Percutaneous nitinol-based vascular closure device for large bore arterial access hemostasis: Results of a prospective multicenter study.
    Catheter Cardiovasc Interv. 2020;96:473-478.
    PubMed     Abstract available


  480. GUREVICH S, Prins KW
    The evolving role of interventional cardiology in the treatment of pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Aug 1. doi: 10.1002/ccd.29146.
    PubMed     Abstract available


    July 2020
  481. SHAH H, Ramineni G, Varghese R, Thwe EE, et al
    Outcomes of percutaneous coronary interventions in patients with liver transplant.
    Catheter Cardiovasc Interv. 2020 Jul 29. doi: 10.1002/ccd.29168.
    PubMed     Abstract available


  482. SIUDAK Z, Grygier M, Wojakowski W, Malinowski KP, et al
    Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2020 Jul 20. doi: 10.1002/ccd.29134.
    PubMed     Abstract available


  483. POPOVIC B, Varlot J, Metzdorf PA, Jeulin H, et al
    Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection.
    Catheter Cardiovasc Interv. 2020 Jul 15. doi: 10.1002/ccd.29114.
    PubMed     Abstract available


  484. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    PubMed     Abstract available


  485. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    PubMed     Abstract available


  486. BUTMAN SM
    Revascularization for multivessel disease: Getting closer, but....
    Catheter Cardiovasc Interv. 2020;96:52.
    PubMed     Abstract available


  487. GRINES CL, Cox D
    Can percutaneous coronary interventions be performed safely in leukemia patients?
    Catheter Cardiovasc Interv. 2020;96:64-65.
    PubMed     Abstract available


  488. HERING D, Heuser RR
    Belt and suspenders: Why it pays to protect and cover during carotid stenting.
    Catheter Cardiovasc Interv. 2020;96:128.
    PubMed     Abstract available


  489. COSTELLO B, Krajcer Z
    Assessing atherothrombotic burden with optical coherence tomography analysis may facilitate post-PCI prognostication and antiplatelet therapy.
    Catheter Cardiovasc Interv. 2020;96:98-99.
    PubMed     Abstract available


  490. SRIDHARAN A, Kimmelstiel C
    Morphine in primary percutaneous coronary intervention-No pain, questionable gain.
    Catheter Cardiovasc Interv. 2020;96:89-90.
    PubMed     Abstract available


  491. CHENEY A, Dean LS
    State-of-the-art percutaneous coronary interventions applied to the treatment of bifurcation lesions: Are we there yet?
    Catheter Cardiovasc Interv. 2020;96:18-19.
    PubMed     Abstract available


  492. ARANZULLA TC, Musumeci G
    True caring is protecting who is at your side.
    Catheter Cardiovasc Interv. 2020;96:29-30.
    PubMed     Abstract available


  493. BACK SH, Gray WA
    Peripheral vascular disease in women: Are we analyzing the costs correctly?
    Catheter Cardiovasc Interv. 2020;96:143-144.
    PubMed     Abstract available


  494. PICCOLO R, Esposito G
    Ticagrelor monotherapy in patients undergoing percutaneous coronary intervention for bifurcation lesions.
    Catheter Cardiovasc Interv. 2020;96:112-113.
    PubMed     Abstract available


  495. ZIMARINO M, Barbato E, Nakamura S, Radico F, et al
    The impact of the extent of side branch disease on outcomes following bifurcation stenting.
    Catheter Cardiovasc Interv. 2020;96:E84-E92.
    PubMed     Abstract available


  496. SHISHIDO K, Moriyama N, Hayashi T, Yokota S, et al
    The efficacy of modified jailed balloon technique for true bifurcation lesions.
    Catheter Cardiovasc Interv. 2020;96:20-28.
    PubMed     Abstract available


  497. ANDREASEN LN, Holm NR, Webber B, Ormiston JA, et al
    Critical aspects of balloon position during final proximal optimization technique (POT) in coronary bifurcation stenting.
    Catheter Cardiovasc Interv. 2020;96:31-39.
    PubMed     Abstract available


  498. AMOROSO G, van der Brug S, Franx V, van Dullemen A, et al
    Slender versus conventional approach reduces post-procedural upper extremity dysfunction after transradial coronary procedures.
    Catheter Cardiovasc Interv. 2020;96:66-73.
    PubMed     Abstract available


  499. SZERLIP M, Feldman DN, Aronow HD, Blankenship JC, et al
    SCAI publications committee manual of standard operating procedures.
    Catheter Cardiovasc Interv. 2020;96:145-155.
    PubMed     Abstract available


  500. IANNACCONE M, D'Ascenzo F, Gallone G, Mitomo S, et al
    Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes.
    Catheter Cardiovasc Interv. 2020;96:1-9.
    PubMed     Abstract available


  501. GRAY WA, Levy E, Bacharach JM, Metzger DC, et al
    Evaluation of a novel mesh-covered stent for treatment of carotid stenosis in patients at high risk for endarterectomy: 1-year results of the SCAFFOLD trial.
    Catheter Cardiovasc Interv. 2020;96:121-127.
    PubMed     Abstract available


  502. KUMAR K, Reddy S, Acharya D, Lotun K, et al
    Novel technique of performing multivessel PCI through an Impella sheath.
    Catheter Cardiovasc Interv. 2020;96:117-120.
    PubMed     Abstract available


  503. WOLLMUTH J, Korngold E, Croce K, Pinto DS, et al
    The Single-access for Hi-risk PCI (SHiP) technique.
    Catheter Cardiovasc Interv. 2020;96:114-116.
    PubMed     Abstract available


  504. AKKAYA E, Sozener K, Rixe J, Tsiakou M, et al
    Venous access closure using a purse-string suture without heparin antagonism or additional compression after MitraClip implantation.
    Catheter Cardiovasc Interv. 2020;96:179-186.
    PubMed     Abstract available


  505. VO MN, Brilakis ES, Pershad A, Grantham JA, et al
    Modified subintimal transcatheter withdrawal: A novel technique for hematoma decompression to facilitate distal reentry during coronary chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2020;96:E98-E101.
    PubMed     Abstract available


  506. LIU J, Li L, Chen C, Wei J, et al
    Modified kissing balloon inflation associated with better results after Culotte stenting for bifurcation lesions: A bench test.
    Catheter Cardiovasc Interv. 2020;96:E34-E44.
    PubMed     Abstract available


  507. KATSIKIS A, Keeble TR, Davies JR, Jagathesan R, et al
    Contemporary management of stent thrombosis: Predictors of mortality and the role of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2020;96:E8-E16.
    PubMed     Abstract available


  508. CERRATO E, Barbero U, Quadri G, Ryan N, et al
    Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III st
    Catheter Cardiovasc Interv. 2020;96:E17-E26.
    PubMed     Abstract available


  509. CHAN YH, Cheng VYH, Wong CW, Lam CS, et al
    A simplified reverse wire technique using an angulated supercross microcatheter.
    Catheter Cardiovasc Interv. 2020;96:E93-E97.
    PubMed     Abstract available


  510. CASANA R, Tolva VS, Odero A Jr, Malloggi C, et al
    Carotid artery stenting is safe and effective for symptomatic patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020;96:129-135.
    PubMed     Abstract available


  511. MODOLO R, Kogame N, Komiyama H, Chichareon P, et al
    Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study.
    Catheter Cardiovasc Interv. 2020;96:10-17.
    PubMed     Abstract available


    June 2020
  512. NIKOLAKOPOULOS I, Choi JW, Alaswad K, Khatri JJ, et al
    Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2020 Jun 29. doi: 10.1002/ccd.29106.
    PubMed     Abstract available


  513. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    PubMed    


  514. KAPUR NK, Hirst CS, Davila CD, Garcia R, et al
    Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29073.
    PubMed     Abstract available


  515. CHUGH Y, Bavishi C, Mojadidi MK, Elgendy IY, et al
    Safety of transradial access compared to transfemoral access with hemostatic devices (vessel plugs and suture devices) after percutaneous coronary interventions: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.29061.
    PubMed     Abstract available


  516. KARACSONYI J, Brilakis ES
    Percutaneous coronary intervention: The "oculosufficient" effect and how to overcome it.
    Catheter Cardiovasc Interv. 2020;95:1267-1268.
    PubMed     Abstract available


  517. GRINES CL, Tummala P, Marshall JJ
    STEMI in the cancer patient: Do not withhold primary PCI!
    Catheter Cardiovasc Interv. 2020;95:1275-1276.
    PubMed     Abstract available


  518. CLEGG S, Blankenship JC
    Post-dilatation trepidation: Post-dil is "no big dil".
    Catheter Cardiovasc Interv. 2020;95:1257-1258.
    PubMed     Abstract available


  519. MELNICK G, Ferrone M, Cheng Y, Conditt GB, et al
    Long-term performance and biocompatibility of a novel bioresorbable scaffold for peripheral arteries: A three-year pilot study in Yucatan miniswine.
    Catheter Cardiovasc Interv. 2020;95:1277-1284.
    PubMed     Abstract available


  520. TANASE D, Georgiev S, Eicken A, Ewert P, et al
    Transcatheter creation of bidirectional cavopulmonary connections by needle punctures in two patients.
    Catheter Cardiovasc Interv. 2020;95:1305-1309.
    PubMed     Abstract available


  521. NAKAMA T, Obunai K, Muraishi M, Watanabe H, et al
    Percutaneous endoluminal anatomical bypass for patients with external iliac artery occlusion after failed conventional endovascular recanalization.
    Catheter Cardiovasc Interv. 2020;95:1320-1326.
    PubMed     Abstract available


  522. MEMON S, Janzer S, Kalra S, George JC, et al
    Recanalization of superior mesenteric artery chronic total occlusion using hybrid algorithm and dissection reentry device.
    Catheter Cardiovasc Interv. 2020;95:1314-1319.
    PubMed     Abstract available


  523. SAITO S, Ikeda N, Toi S, Nakamura M, et al
    Gadolinium contrast balloon pulmonary angioplasty for a patient with chronic thromboembolic pulmonary hypertension and severe iodine allergy.
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29004.
    PubMed     Abstract available


  524. CONROTTO F, D'Ascenzo F, Piroli F, Franze A, et al
    Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29048.
    PubMed     Abstract available


    May 2020
  525. SEIF S, Ayuna A, Kumar A, Macdonald J, et al
    Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 May 30. doi: 10.1002/ccd.29050.
    PubMed     Abstract available


  526. ELEID MF, Zheng PP, Gulati R, Bergman P, et al
    Remote robotic percutaneous coronary intervention: An animal feasibility study.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28978.
    PubMed     Abstract available


  527. TABAZA L, Virk HUH, Janzer S, George JC, et al
    Robotic-assisted percutaneous coronary intervention in a COVID-19 patient.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28982.
    PubMed     Abstract available


  528. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  529. EFFOE VS, Kumar G, Sachdeva R
    Intravascular ultrasound-guided pulmonary artery embolectomy for saddle pulmonary embolism.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28985.
    PubMed     Abstract available


  530. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    PubMed    


  531. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    PubMed     Abstract available


  532. HIGUCHI S, Kabeya Y, Nishina Y, Miura Y, et al
    Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28958.
    PubMed     Abstract available


  533. FERLINI M, Musumeci G, Grieco N, Trabattoni D, et al
    Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28964.
    PubMed     Abstract available


  534. VIRK HUH, Lakhter V, Tabaza L, George JC, et al
    Do we need robotics for coronary intervention more than ever in the COVID-19 era?
    Catheter Cardiovasc Interv. 2020 May 7. doi: 10.1002/ccd.28949.
    PubMed    


  535. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    PubMed     Abstract available


  536. OOI YS, Gray WA
    Taking the kidney to heart.
    Catheter Cardiovasc Interv. 2020;95:1122-1123.
    PubMed     Abstract available


  537. CHIARITO M, Mehran R
    Panta rhei, also drug eluting stent technology.
    Catheter Cardiovasc Interv. 2020;95:1074-1075.
    PubMed     Abstract available


  538. TOMMASO CL
    Stenting in unprotected left main coronary stenosis-"What no progress"?
    Catheter Cardiovasc Interv. 2020;95:1092-1093.
    PubMed     Abstract available


  539. SHATILA W, Krajcer Z
    Thoracic aortic disease: Can we safely cover the branches?
    Catheter Cardiovasc Interv. 2020;95:1169-1170.
    PubMed     Abstract available


  540. BAI J, Liu Y, Jin J, Wu J, et al
    Mid-term results of in situ fenestration stented with balloon-expandable bare metal stents during thoracic endovascular aortic repair.
    Catheter Cardiovasc Interv. 2020;95:1163-1168.
    PubMed     Abstract available


  541. SMITH CL, Saul D, Goldfarb SB, Biko DM, et al
    Compression of the left mainstem bronchus by patent ductus arteriosus in neonates under consideration for ductal stenting.
    Catheter Cardiovasc Interv. 2020;95:1158-1162.
    PubMed     Abstract available


  542. ONO S, Shimogawara T, Yamazoe S, Matsui J, et al
    Successful endovascular isolation of a huge true anterior tibial artery aneurysm by the bi-directional approach in a young patient.
    Catheter Cardiovasc Interv. 2020;95:E175-E178.
    PubMed     Abstract available


  543. HAUDE M, Lee SWL, Worthley SG, Silber S, et al
    The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.
    Catheter Cardiovasc Interv. 2020;95:1076-1084.
    PubMed     Abstract available


  544. VAN ZANDVOORT LJC, van Bommel RJ, Masdjedi K, Tovar Forero MN, et al
    Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2020;95:1085-1091.
    PubMed     Abstract available


    April 2020
  545. XIAO Z, Xu C, Wang D, Zeng H, et al
    The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.
    Catheter Cardiovasc Interv. 2020 Apr 29. doi: 10.1002/ccd.28951.
    PubMed     Abstract available


  546. AZZALINI L, Johal GS, Baber U, Bander J, et al
    Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28931.
    PubMed     Abstract available


  547. SADEGHIPOUR P, Talasaz AH, Eslami V, Gerayeli B, et al
    Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28889.
    PubMed     Abstract available


  548. MAHMUD E, Dauerman HL, Welt FG, Messenger JC, et al
    Management of Acute Myocardial Infarction During the COVID-19 Pandemic.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28946.
    PubMed     Abstract available


  549. HARA H, Kogame N, Takahashi K, Modolo R, et al
    Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28898.
    PubMed     Abstract available


  550. THOMSON VS, Varghese MJ, Chacko ST, Varghese L, et al
    Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28897.
    PubMed     Abstract available


  551. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    PubMed     Abstract available


  552. MEGALY M, Brilakis ES
    Telesupported procedures: when and how.
    Catheter Cardiovasc Interv. 2020;95:911-913.
    PubMed     Abstract available


  553. KATARUKA A, Dean LS
    Uncommon but devastating: Stroke after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020;95:893-894.
    PubMed     Abstract available


  554. MUSUMECI G, Baralis G
    Coronary total occlusion and minimalist approach: When less is more.
    Catheter Cardiovasc Interv. 2020;95:E150-E151.
    PubMed    


  555. BUTERA G, Lucchese G, Austin C, Frigiola A, et al
    Hybrid trans-apical atrioventricular valve-in-valve implantation in Fontan circulation.
    Catheter Cardiovasc Interv. 2020;95:950-953.
    PubMed     Abstract available


  556. SHAH AH, Osten M, Benson L, Alnasser S, et al
    Long-term outcomes of percutaneous closure of coronary artery fistulae in the adult: A single-center experience.
    Catheter Cardiovasc Interv. 2020;95:939-948.
    PubMed     Abstract available


  557. FENDER EA, Widmer RJ, Mahowald MK, Hodge DO, et al
    Recurrent pulmonary vein stenosis after successful intervention: Prognosis and management of restenosis.
    Catheter Cardiovasc Interv. 2020;95:954-958.
    PubMed     Abstract available


  558. MADDER RD, VanOosterhout S, Mulder A, Bush J, et al
    Network latency and long-distance robotic telestenting: Exploring the potential impact of network delays on telestenting performance.
    Catheter Cardiovasc Interv. 2020;95:914-919.
    PubMed     Abstract available


  559. SALAHUDDIN S, Faizal A, Koshy S, Moideen Koya M, et al
    An unusual shot-retrograde transthoraco-abdominal venous bullet embolization.
    Catheter Cardiovasc Interv. 2020;95:978-981.
    PubMed     Abstract available


  560. ADACHI T, Sato A, Kuroki K, Terai T, et al
    Audiovisual telesupport system for cardiovascular catheter interventions: A preliminary report on the clinical implications.
    Catheter Cardiovasc Interv. 2020;95:906-910.
    PubMed     Abstract available


  561. MAZZACCARO D, Castronovo EL, Righini P, Nano G, et al
    Use of steerable catheters for endovascular procedures: Report of a CASE and literature review.
    Catheter Cardiovasc Interv. 2020;95:971-977.
    PubMed     Abstract available


  562. YANG HM, Lim HS, Yoon MH, Seo KW, et al
    Usefulness of the trans-stent fractional flow reserve gradient for predicting clinical outcomes.
    Catheter Cardiovasc Interv. 2020;95:E123-E129.
    PubMed     Abstract available


  563. WIPER A, Amoroso G, Rao S, Nolan J, et al
    Complex regional pain syndrome: A rare but potentially disabling complication of transradial cardiac catheterization.
    Catheter Cardiovasc Interv. 2020;95:E140-E143.
    PubMed     Abstract available


    March 2020
  564. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    PubMed     Abstract available


  565. GIANNINI F, Pagnesi M, Campo G, Donahue M, et al
    Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28798.
    PubMed     Abstract available


  566. CHANDRASEKHAR J, Kerkmeijer LS, Kalkman DN, Sartori S, et al
    Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28853.
    PubMed     Abstract available


  567. BRENER SJ, Lembo NJ, Kandzari DE, Sabate M, et al
    Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28858.
    PubMed     Abstract available


  568. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    PubMed     Abstract available


  569. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    PubMed     Abstract available


  570. PRASAD A, Rosenthal NA, Kartashov A, Knish K, et al
    Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28824.
    PubMed     Abstract available


  571. MANNING P, Abbott JD
    Radial access: So much progress but a way to go.
    Catheter Cardiovasc Interv. 2020;95:684-685.
    PubMed     Abstract available


  572. KRAJCER Z, Costello BT
    Editorial for: Outcomes after endovascular mechanical thrombectomy in occluded vascular access used for dialysis purposes.
    Catheter Cardiovasc Interv. 2020;95:765-766.
    PubMed     Abstract available


  573. GRINES CL, Marshall JJ
    Invasive imaging of myocardial infarction patients: Is less or more better?
    Catheter Cardiovasc Interv. 2020;95:704-705.
    PubMed     Abstract available


  574. RIANGWIWAT T, Blankenship JC
    Side branches don't get respect.
    Catheter Cardiovasc Interv. 2020;95:694-695.
    PubMed    


  575. DE GREGORIO J, Bailey SR
    ISCHEMIA from a clinicians perspective: Treating the patient or the investigator?
    Catheter Cardiovasc Interv. 2020;95:711-712.
    PubMed    


  576. DROUVEN JW, de Bruin C, van Roon AM, Oldenziel J, et al
    Outcomes after endovascular mechanical thrombectomy in occluded vascular access used for dialysis purposes.
    Catheter Cardiovasc Interv. 2020;95:758-764.
    PubMed     Abstract available


  577. KOKKINIDIS DG, Strobel A, Jawaid O, Haider MN, et al
    Development and validation of a predictive score for anterograde crossing of infrapopliteal chronic total occlusions: (The Infrapop-CTO Score).
    Catheter Cardiovasc Interv. 2020;95:748-755.
    PubMed     Abstract available


  578. KARAHALIOS B, Rojas SF, Singh R, Cavazos MC, et al
    Torque device suture technique to achieve hemostasis in large-bore venous access.
    Catheter Cardiovasc Interv. 2020;95:722-725.
    PubMed     Abstract available


  579. BAUSER-HEATON H, Qureshi AM, Goldstein BH, Glatz AC, et al
    Use of carotid and axillary artery approach for stenting the patent ductus arteriosus in infants with ductal-dependent pulmonary blood flow: A multicenter study from the congenital catheterization research collaborative.
    Catheter Cardiovasc Interv. 2020;95:726-733.
    PubMed     Abstract available


  580. ORR WB, Johnson MC, Abarbanell AM, Sintek M, et al
    Recanalization of an atretic intramural left main coronary artery after bypass surgery in a pediatric patient with anomalous aortic origin of the left main coronary artery arising from the right sinus of Valsalva.
    Catheter Cardiovasc Interv. 2020;95:739-742.
    PubMed     Abstract available


  581. SORENSEN MW, Bauser-Heaton H, Petit CJ
    Percutaneous paraspinal access to the azygos vein to create a neo-vena cava.
    Catheter Cardiovasc Interv. 2020;95:734-738.
    PubMed     Abstract available


  582. ABDUL JABBAR A, Chanda A, White CJ, Jenkins JS, et al
    Percutaneous endovascular abdominal aneurysm repair: State-of-the art.
    Catheter Cardiovasc Interv. 2020;95:767-782.
    PubMed     Abstract available


  583. WANG Z, Wang C, Li F, Zhao Y, et al
    Endovascular repair during complex thoracic aortic dissection using a micropore stent graft: Midterm follow-up clinical outcomes.
    Catheter Cardiovasc Interv. 2020;95:E111-E119.
    PubMed     Abstract available


  584. RAGHUNATHAN D, Hernandez N, Rajagopal K, Jumean M, et al
    Axillary Impella insertion under regional nerve block: A case report.
    Catheter Cardiovasc Interv. 2020;95:E108-E110.
    PubMed     Abstract available


  585. MIRANDA WR, Hagler DJ, Taggart NW, Borlaug BA, et al
    Elevated ventricular filling pressures and long-term survival in adults post-Fontan.
    Catheter Cardiovasc Interv. 2020;95:803-809.
    PubMed     Abstract available


  586. CHESTER RC, Mina SA, Lewis B, Zhang N, et al
    Radial artery access is under-utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI Registry.
    Catheter Cardiovasc Interv. 2020;95:675-683.
    PubMed     Abstract available


    February 2020
  587. KWOK CS, Chatterjee S, Bagur R, Sharma K, et al
    Multiple unplanned readmissions after discharge for an admission with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 28. doi: 10.1002/ccd.28797.
    PubMed     Abstract available


  588. HUDED CP, Kapadia SR, Ballout JA, Krishnaswamy A, et al
    Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28785.
    PubMed     Abstract available


  589. KHEIRI B, Rao SV, Osman M, Simpson TF, et al
    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28800.
    PubMed     Abstract available


  590. AOI S, Baber U, Kovacic JC, Mehran R, et al
    Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28784.
    PubMed     Abstract available


  591. NOAMAN S, O'Brien J, Andrianopoulos N, Brennan AL, et al
    Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28802.
    PubMed     Abstract available


  592. TARANTINI G, Nai Fovino L
    Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;95:363-364.
    PubMed    


  593. TOPAZ O
    PEI for allograft renal artery stenosis: a unique role and broad implications for renal artery stenosis treatment.
    Catheter Cardiovasc Interv. 2020;95:437-438.
    PubMed    


  594. YILDIZ M, Henry TD
    Preprocedure Thrombolysis In Myocardial Infarction (TIMI) flow grade: Has its time come and gone?
    Catheter Cardiovasc Interv. 2020;95:501-502.
    PubMed    


  595. AYYOUB A, Levy MS
    Mechanical circulatory support in high-risk percutaneous coronary intervention: IIb or not IIb?
    Catheter Cardiovasc Interv. 2020;95:513-514.
    PubMed    


  596. MUSTAPHA JA, Saab F, McGoff TN, Adams G, et al
    Tibiopedal arterial minimally invasive retrograde revascularization (TAMI) in patients with peripheral arterial disease and critical limb ischemia. On behalf of the Peripheral Registry of Endovascular Clinical Outcomes (PRIME).
    Catheter Cardiovasc Interv. 2020;95:447-454.
    PubMed     Abstract available


  597. KOKKINIDIS DG, Behan S, Jawaid O, Hossain P, et al
    Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Catheter Cardiovasc Interv. 2020;95:439-446.
    PubMed     Abstract available


  598. REN Y, Xiong F, Kan X, Qian K, et al
    Endovascular management of transplant renal artery stenosis: A single-center retrospective study.
    Catheter Cardiovasc Interv. 2020;95:429-436.
    PubMed     Abstract available


  599. SUNTHAROS P, Worley SE, Liu W, Siperstein M, et al
    Long-term outcome of percutaneous intervention for pulmonary vein stenosis after pulmonary vein isolation procedure.
    Catheter Cardiovasc Interv. 2020;95:389-397.
    PubMed     Abstract available


  600. MASCHIETTO N, Baird C, Porras D
    Percutaneous intraluminal downsizing of systemic-to-pulmonary artery shunts: a novel application of the Diabolo stent technique-Case series and description of the technique.
    Catheter Cardiovasc Interv. 2020;95:471-476.
    PubMed     Abstract available


  601. HIREMATH G, Morgan G, Kenny D, Batlivala SP, et al
    Balloon expandable covered stents as primary therapy for hemodynamically stable traumatic aortic injuries in children.
    Catheter Cardiovasc Interv. 2020;95:477-483.
    PubMed     Abstract available


  602. MOUSSA PACHA H, Al-Khadra Y, Darmoch F, Soud M, et al
    In-hospital outcome of peripheral vascular intervention in dialysis-dependent end-stage renal disease patients.
    Catheter Cardiovasc Interv. 2020;95:E84-E95.
    PubMed     Abstract available


  603. D'ASCENZO F, Gaido L, Bernardi A, Saglietto A, et al
    Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.
    Catheter Cardiovasc Interv. 2020;95:522-529.
    PubMed     Abstract available


  604. ROSSEEL L, De Backer O, Sondergaard L, Bieliauskas G, et al
    Intravascular iliac artery lithotripsy to enable transfemoral thoracic endovascular aortic repair.
    Catheter Cardiovasc Interv. 2020;95:E96-E99.
    PubMed     Abstract available


  605. SHAH SR, Kiemeneij F, Khuddus MA
    Distal arteriovenous fistula formation after percutaneous coronary intervention: An old complication of a new access site.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28772.
    PubMed     Abstract available


  606. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Long-term effect of remote ischemic conditioning on infarct size and clinical outcomes in patients with anterior ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28760.
    PubMed     Abstract available


  607. MUSUMECI G, Baralis G
    Bioresorbable scaffold: Never say never.
    Catheter Cardiovasc Interv. 2020;95:224-225.
    PubMed     Abstract available


  608. BIENEK S, Kusmierczuk M, Mittag A, Bettink S, et al
    Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
    Catheter Cardiovasc Interv. 2020;95:319-328.
    PubMed     Abstract available


  609. KIESZ RS, Gora B, Kolarczyk-Haczyk A, Kachel M, et al
    Clinical significance of mirror lesions in lower extremity arterial disease.
    Catheter Cardiovasc Interv. 2020;95:300-306.
    PubMed     Abstract available


  610. SMITH CL, Hoffman TM, Dori Y, Rome JJ, et al
    Decompression of the thoracic duct: A novel transcatheter approach.
    Catheter Cardiovasc Interv. 2020;95:E56-E61.
    PubMed     Abstract available


  611. IANNACCONE M, Colangelo S, Colombo F, Garbo R, et al
    Rotational atherectomy with the new RotaPro system over RG3 guidewire in subadventitial retrograde highly calcified CTO PCI.
    Catheter Cardiovasc Interv. 2020;95:242-244.
    PubMed     Abstract available


  612. TABAZA L, Janzer S, George JC
    Stent crush: A novel endovascular approach for treatment of complex in-stent femoropopliteal chronic total occlusion.
    Catheter Cardiovasc Interv. 2020;95:E66-E70.
    PubMed     Abstract available


  613. FORD TJ, Khan A, Docherty KF, Jackson A, et al
    Sex differences in procedural and clinical outcomes following rotational atherectomy.
    Catheter Cardiovasc Interv. 2020;95:232-241.
    PubMed     Abstract available


  614. INIGUEZ A, Chevalier B, Richardt G, Neylon A, et al
    Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized cli
    Catheter Cardiovasc Interv. 2020;95:175-184.
    PubMed     Abstract available


  615. GOEL S, Pasam RT, Chava S, Sharma A, et al
    Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis.
    Catheter Cardiovasc Interv. 2020;95:216-223.
    PubMed     Abstract available


  616. JIA S, Guan C, Yuan J, Cao X, et al
    Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort.
    Catheter Cardiovasc Interv. 2020;95:206-215.
    PubMed     Abstract available


  617. CORTESE B, Alfonso F, Pellegrini D, Sing KR, et al
    The hypothesis of an increased mortality following paclitaxel coated device use in peripheral vascular interventions (and the emerging era of meta-analysis based evidence).
    Catheter Cardiovasc Interv. 2020;95:329-331.
    PubMed    


  618. GAO R, Xu B
    CCI and CIT 2020-A special year of the special issue.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:532-533.
    PubMed    


  619. BAILEY SR
    CCI 2020 CIT special issue.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:531.
    PubMed    


  620. LIU Y, Zhang Y, Li Y, Qi T, et al
    One-year clinical results of the NANO registry: A multicenter, prospective all-comers registry study in patients receiving implantation of a polymer-free sirolimus-eluting stent.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:658-664.
    PubMed     Abstract available


  621. WANG G, Ma G, Tao L, Yuan Z, et al
    Three-year follow up of biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: Pooled analysis of CREDIT II and CREDIT III trials.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:565-571.
    PubMed     Abstract available


  622. TIAN J, Tang YD, Qiao S, Su X, et al
    Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:587-597.
    PubMed     Abstract available


  623. CHEN Y, Dong H, Jiang X, Deng Y, et al
    Percutaneous transluminal angioplasty with selective stenting for the treatment of renal artery stenosis caused by fibromuscular dysplasia: 18 years' experience from the China Center for Cardiovascular Disease.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:641-647.
    PubMed     Abstract available


  624. ZHAO X, Guan C, Yuan J, Xie L, et al
    A modified predilation, sizing, and postdilation scoring system for patients undergoing metallic drug-eluting stent implantations.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:558-564.
    PubMed     Abstract available


  625. CHE W, Dong H, Jiang X, Xiong H, et al
    The effect of stenting on blood pressure in hypertensive patients with symptomatic proximal subclavian or vertebral artery stenosis.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:633-640.
    PubMed     Abstract available


    January 2020
  626. MAHMUD E
    The COMPLETE and ISCHEMIA trials: Two contemporary studies showing percutaneous coronary intervention reduces the risk of myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 29. doi: 10.1002/ccd.28723.
    PubMed    


  627. QUADROS A, Belli KC, de Paula JET, de Magalhaes Campos CAH, et al
    Chronic total occlusion percutaneous coronary intervention in Latin America.
    Catheter Cardiovasc Interv. 2020 Jan 28. doi: 10.1002/ccd.28744.
    PubMed     Abstract available


  628. BUGANI G, Ponticelli F, Giannini F, Gallo F, et al
    Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 22. doi: 10.1002/ccd.28740.
    PubMed     Abstract available


  629. TYLER JM, Henry TD
    Intraaortic balloon pump in myocardial infarction: Always, Never, or for the Right Patient?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28683.
    PubMed     Abstract available


  630. BLOCK PC, Kumar A
    Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686.
    PubMed     Abstract available


  631. GILCHRIST IC
    Gastrointestinal bleeding after percutaneous coronary intervention: Not just a short-term complication but a long-term marker of mortality risk.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28680.
    PubMed     Abstract available


  632. YOU J, Li H, Guo W, Li J, et al
    Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28712.
    PubMed     Abstract available


  633. ALAWAMI M, Thirunavukarasu S, Ahmed J, El-Omar M, et al
    Intravascular lithotripsy to treat an underexpanded coronary stent: 4-Month angiographic and OCT follow-up.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28738.
    PubMed     Abstract available


  634. XU MX, Ruddy TD, Schoenhagen P, Bartel T, et al
    The CatLet score and outcome prediction in acute myocardial infarction for patients undergoing primary percutaneous intervention: A proof-of-concept study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28724.
    PubMed     Abstract available


  635. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  636. SHAO C, Wang J, Li P, Yang J, et al
    Evaluation of a risk index for predicting short-term and long-term outcomes in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28706.
    PubMed     Abstract available


  637. ZHAO X, Li J, Xian Y, Chen J, et al
    Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28719.
    PubMed     Abstract available


  638. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    PubMed     Abstract available


  639. SHENG X, Qiao Z, Ge H, Sun J, et al
    Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28718.
    PubMed     Abstract available


  640. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-glutamyl transferase to albumin ratio as a novel predictor of bleeding events and mortality in patients after percutaneous coronary intervention: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28696.
    PubMed     Abstract available


  641. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


  642. PRANATA R, Tondas AE, Vania R, Toruan MPL, et al
    Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28709.
    PubMed     Abstract available


  643. COSTANTINI CR, Denk MA, De Macedo RM, Tarbine SG, et al
    Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28699.
    PubMed     Abstract available


  644. SONG L, Sun Z, Guan C, Yan H, et al
    First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes.
    Catheter Cardiovasc Interv. 2020 Jan 7. doi: 10.1002/ccd.28722.
    PubMed     Abstract available


  645. VALENTI R, Migliorini A, De Gregorio MG, Martone R, et al
    Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion.
    Catheter Cardiovasc Interv. 2020;95:145-153.
    PubMed     Abstract available


  646. CEREDA AF, De Luca F, Lanzone AM, Cottini M, et al
    Case report and systematic review of iatrogenic left atrial dissection in different cardiovascular specialties: A common treatment for an uncommon complication?
    Catheter Cardiovasc Interv. 2020;95:E30-E36.
    PubMed     Abstract available


  647. XENOGIANNIS I, Vemmou E, Nikolakopoulos I, Brilakis ES, et al
    Challenges associated with treatment of left internal mammary artery graft thrombosis.
    Catheter Cardiovasc Interv. 2020;95:E17-E20.
    PubMed     Abstract available


  648. KITANO D, Takayama T, Fukamachi D, Migita S, et al
    Impact of low-dose prasugrel on platelet reactivity and cardiac dysfunction in acute coronary syndrome patients requiring primary drug-eluting stent implantation: A randomized comparative study.
    Catheter Cardiovasc Interv. 2020;95:E8-E16.
    PubMed     Abstract available


  649. FIORILLI PN, Kobayashi T, Giri J, Hirshfeld JW Jr, et al
    Strategies for radiation exposure-sparing in fluoroscopically guided invasive cardiovascular procedures.
    Catheter Cardiovasc Interv. 2020;95:118-127.
    PubMed     Abstract available


  650. MIZUTANI K, Hara M, Nakao K, Yamaguchi T, et al
    Association between debulking area of rotational atherectomy and platform revolution speed-Frequency domain optical coherence tomography analysis.
    Catheter Cardiovasc Interv. 2020;95:E1-E7.
    PubMed     Abstract available


  651. MERINOPOULOS I, Wickramarachchi U, Wardley J, Khanna V, et al
    Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:105-108.
    PubMed     Abstract available


  652. ZIVELONGHI C, van Kuijk JP, Poletti E, Suttorp MJ, et al
    A "minimalistic hybrid algorithm" in coronary chronic total occlusion revascularization: Procedural and clinical outcomes.
    Catheter Cardiovasc Interv. 2020;95:97-104.
    PubMed     Abstract available


  653. CHAN CY, Chan YH
    Double trapper technique: A novel technique to facilitate retrograde wire externalization in aorto-ostial chronic total occlusion intervention without using snare.
    Catheter Cardiovasc Interv. 2020;95:170-173.
    PubMed     Abstract available


  654. SURYADEVARA R, Brown ED, Green SM, Scott TD, et al
    A randomized controlled trial to assess operator radiation exposure from cardiac catheterization procedures using RAD BOARD(R) with standard pelvic shielding versus standard pelvic shielding alone.
    Catheter Cardiovasc Interv. 2020;95:83-88.
    PubMed     Abstract available


    December 2019
  655. GARCIA-GARCIA HM, Adamo M, Soud M, Yacob O, et al
    Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX)
    Catheter Cardiovasc Interv. 2019 Dec 28. doi: 10.1002/ccd.28661.
    PubMed     Abstract available


  656. SHROFF AR, Gulati R, Drachman DE, Feldman DN, et al
    SCAI expert consensus statement update on best practices for transradial angiography and intervention.
    Catheter Cardiovasc Interv. 2019 Dec 27. doi: 10.1002/ccd.28672.
    PubMed     Abstract available


  657. GAO G, Zhang D, Song C, Xu H, et al
    Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28673.
    PubMed     Abstract available


  658. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    PubMed     Abstract available


  659. LI J, Li Y, Qiu M, Li Z, et al
    Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28653.
    PubMed     Abstract available


  660. YAN L, Li P, Wang Y, Han D, et al
    Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28652.
    PubMed     Abstract available


  661. KHEIFETS M, Vaknin-Assa H, Greenberg G, Assali A, et al
    Outcomes of primary percutaneous cardiac intervention for ST elevation myocardial infarction with a saphenous vein graft culprit.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28662.
    PubMed     Abstract available


  662. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    PubMed     Abstract available


  663. YAP J, Teo TY, Foong P, Binte Hussin N, et al
    A randomized controlled trial on the effectiveness of a portable patient education video prior to coronary angiography and angioplasty.
    Catheter Cardiovasc Interv. 2019 Dec 22. doi: 10.1002/ccd.28655.
    PubMed     Abstract available


  664. NAGARAJA V, Schwarz K, Moss S, Kwok CS, et al
    Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28646.
    PubMed     Abstract available


  665. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  666. RIANGWIWAT T, Mumtaz T, Blankenship JC
    Barriers to use of radial access for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28619.
    PubMed     Abstract available


  667. XENOGIANNIS I, Choi JW, Alaswad K, Khatri JJ, et al
    Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28614.
    PubMed     Abstract available


  668. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


  669. CHANDIRAMANI R, Mehran R
    Examining the role of diabetes mellitus in ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019;94:926-927.
    PubMed    


    November 2019
  670. OMRAN J, Enezate T, Abdullah O, Al-Dadah A, et al
    Outcomes of fractional flow reserve-guided percutaneous coronary interventions in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28611.
    PubMed     Abstract available


  671. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    PubMed     Abstract available


  672. AMR BS, Lippmann M, Tobbia P, Isom N, et al
    Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions.
    Catheter Cardiovasc Interv. 2019 Nov 26. doi: 10.1002/ccd.28618.
    PubMed     Abstract available


  673. VALLABHAJOSYULA S, El Hajj SC, Bell MR, Prasad A, et al
    Intravascular ultrasound, optical coherence tomography, and fractional flow reserve use in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 14. doi: 10.1002/ccd.28543.
    PubMed     Abstract available


  674. HOLLRIEGEL R, Spindler A, Kiefer P, Woitek FJ, et al
    Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28515.
    PubMed     Abstract available


  675. ALSANJARI O, Chouari T, Williams T, Myat A, et al
    Angiographically visible coronary artery collateral circulation improves prognosis in patients presenting with acute ST segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28532.
    PubMed     Abstract available


  676. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  677. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    PubMed     Abstract available


  678. SULLIVAN AE, Nanna MG, Rao SV, Cantrell S, et al
    A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28535.
    PubMed     Abstract available


  679. XENOGIANNIS I, Nikolakopoulos I, Vemmou E, Brilakis ES, et al
    Chronic total occlusion recanalization for myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28590.
    PubMed     Abstract available


  680. ADAMS HSL, Rajani R, Hildick-Smith D, Redwood S, et al
    "Between a rock and the mitral valve space": Transcatheter mitral valve-in-valve implantation for paravalvular leak and refractory hemolysis complicated by circumflex coronary occlusion.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28573.
    PubMed     Abstract available


  681. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    PubMed     Abstract available


    October 2019
  682. SONG C, Zhou C, Zhang J, Feng X, et al
    Ultrasound controlled paclitaxel releasing system-A novel method for improving the availability of coronary artery drug coated balloon.
    Catheter Cardiovasc Interv. 2019 Oct 29. doi: 10.1002/ccd.28564.
    PubMed     Abstract available


  683. BATCHELOR R, Liu DH, Bloom J, Noaman S, et al
    Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 26. doi: 10.1002/ccd.28561.
    PubMed     Abstract available


  684. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    PubMed     Abstract available


  685. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    PubMed     Abstract available


  686. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  687. YEOH J, Dworakowski R, Hill J, Byrne J, et al
    A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28521.
    PubMed     Abstract available


  688. CANTOR WJ, Lavi S, Dzavik V, Cairns J, et al
    Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28540.
    PubMed     Abstract available


  689. ARMSTRONG AK, Zampi JD, Itu LM, Benson LN, et al
    Use of 3D rotational angiography to perform computational fluid dynamics and virtual interventions in aortic coarctation.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28507.
    PubMed     Abstract available


  690. POLETTI E, Azzalini L, Ayoub M, Ojeda S, et al
    Conventional vascular access site approach versus fully trans-wrist approach for chronic total occlusion percutaneous coronary intervention: a multicenter registry.
    Catheter Cardiovasc Interv. 2019 Oct 9. doi: 10.1002/ccd.28513.
    PubMed     Abstract available


  691. BRENER MI, Green P, Parikh SA, Sethi SS, et al
    Acute pulmonary embolism unmasking underlying chronic thromboembolic pulmonary hypertension and iliac vein compression syndrome.
    Catheter Cardiovasc Interv. 2019 Oct 8. doi: 10.1002/ccd.28525.
    PubMed     Abstract available


    September 2019
  692. STAUDACHER DL, Schmitt C, Zirlik A, Zehender M, et al
    Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2019 Sep 11. doi: 10.1002/ccd.28495.
    PubMed     Abstract available


  693. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    PubMed     Abstract available


  694. HIRAI T, Kearney K, Kataruka A, Gosch KL, et al
    Initial report of safety and procedure duration of robotic-assisted chronic total occlusion coronary intervention.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28477.
    PubMed     Abstract available


  695. WHITBECK MG
    Treatment of focal distal abdominal aortic stenosis with the GORE VIABAHN VBX balloon expandable covered stent.
    Catheter Cardiovasc Interv. 2019 Sep 2. doi: 10.1002/ccd.28478.
    PubMed     Abstract available


  696. TARANTINI G, Giacoppo D
    Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery?
    Catheter Cardiovasc Interv. 2019;94:385-386.
    PubMed     Abstract available


    August 2019
  697. HONG SJ, Kim BK, Kim YJ, Rha SW, et al
    Incidence, predictors, and outcomes of distal vessel expansion on follow-up intravascular ultrasound after recanalization of chronic total occlusions using new-generation drug-eluting stents: Data from the CTO-IVUS randomized trial.
    Catheter Cardiovasc Interv. 2019 Aug 28. doi: 10.1002/ccd.28461.
    PubMed     Abstract available


  698. ALUSHI B, Lauten A, Ndrepepa G, Leistner DM, et al
    Procedural and clinical performance of dual- versus single-catheter strategy for transradial coronary angiography: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28458.
    PubMed     Abstract available


  699. KANDZARI DE, Karmpaliotis D, Kini AS, Moses JW, et al
    Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPER
    Catheter Cardiovasc Interv. 2019 Aug 24. doi: 10.1002/ccd.28436.
    PubMed     Abstract available


  700. NAIDU SS, Daniels MJ, Elmariah S, Garcia S, et al
    Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think Tank.
    Catheter Cardiovasc Interv. 2019 Aug 23. doi: 10.1002/ccd.28449.
    PubMed    


  701. MARQUIS-GRAVEL G, Zeitouni M, Kochar A, Jones WS, et al
    Technical consideration in acute myocardial infarction with cardiogenic shock: A review of antithrombotic and PCI therapies.
    Catheter Cardiovasc Interv. 2019 Aug 21. doi: 10.1002/ccd.28455.
    PubMed     Abstract available


  702. GOEL S, Pasam RT, Raheja H, Gotesman J, et al
    Left main percutaneous coronary intervention-Radial versus femoral access: A systematic analysis.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28451.
    PubMed     Abstract available


  703. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28440.
    PubMed     Abstract available


  704. POTTS J, Mohamed MO, Lopez Mattei JC, Iliescu CA, et al
    Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28432.
    PubMed     Abstract available


  705. KOGAME N, Chichareon P, De Wilder K, Takahashi K, et al
    Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28428.
    PubMed     Abstract available


  706. ROULE V, Schwob L, Lemaitre A, Bignon M, et al
    Residual atherothrombotic burden after primary percutaneous coronary intervention and myocardial reperfusion-An optical frequency domain imaging study.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28429.
    PubMed     Abstract available


  707. IANNACCONE M, Abdirashid M, Annone U, Saint-Hilary G, et al
    Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention: A network meta-analysis of randomized and propensity matching studies.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28410.
    PubMed     Abstract available


  708. DOSHI R, Patel K, Desai R, Patel P, et al
    Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28431.
    PubMed     Abstract available


  709. WATANABE H, Shiomi H, Morimoto T, Furukawa Y, et al
    Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420.
    PubMed     Abstract available


  710. AL-ANI A, Hoffmann P, von Lueder T, Opdahl A, et al
    Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Aug 4. doi: 10.1002/ccd.28419.
    PubMed     Abstract available


    July 2019
  711. FLAHERTY MP, Moses JW, Westenfeld R, Palacios I, et al
    Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Catheter Cardiovasc Interv. 2019 Jul 29. doi: 10.1002/ccd.28400.
    PubMed     Abstract available


  712. CASTRO-MEJIA AF, Ortega-Armas ME, Mejia-Renteria H, Gonzalo N, et al
    Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jul 26. doi: 10.1002/ccd.28404.
    PubMed     Abstract available


  713. KOLTOWSKI L, Tomaniak M, Ochijewicz D, Maksym J, et al
    Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.
    Catheter Cardiovasc Interv. 2019 Jul 25. doi: 10.1002/ccd.28414.
    PubMed     Abstract available


  714. KAR S
    Systematic review of alternative access for cardiac catheterization and percutaneous coronary intervention: Dorsal distal radial and ulnar artery catheterization.
    Catheter Cardiovasc Interv. 2019 Jul 22. doi: 10.1002/ccd.28398.
    PubMed     Abstract available


  715. GASPARINI GL, Garbo R, Gagnor A, Oreglia J, et al
    Feasibility and safety of distal radial access for percutaneous coronary intervention using a 7 FR sheath.
    Catheter Cardiovasc Interv. 2019 Jul 21. doi: 10.1002/ccd.28397.
    PubMed    


  716. SAADAT N, Saadatagah S, Aghajani Nargesi A, Alidoosti M, et al
    Short-term safety and long-term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28396.
    PubMed     Abstract available


  717. LI Y, Tian F, Wang J, Xie M, et al
    Pseudoaneurysm of the non-coronary sinus of Valsalva: A rare complication of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28407.
    PubMed     Abstract available


  718. RAFEEDHEEN R, Agarwal SK, Meek JC, Uretsky BF, et al
    Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28399.
    PubMed     Abstract available


  719. KIRTANE AJ, Yeung AC, Ball M, Carr J, et al
    Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.
    Catheter Cardiovasc Interv. 2019 Jul 13. doi: 10.1002/ccd.28392.
    PubMed     Abstract available


  720. POSTMA W, Fabris E, Van der Ent M, Hermanides R, et al
    Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial.
    Catheter Cardiovasc Interv. 2019 Jul 3. doi: 10.1002/ccd.28376.
    PubMed     Abstract available


    June 2019
  721. HE Y, Cheng XF, Wang K, Liu T, et al
    Predictive value of combining the SYNTAX score with reactive hyperemia index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 29. doi: 10.1002/ccd.28384.
    PubMed     Abstract available


  722. AL-KHADRA Y, Alraies MC, Darmoch F, Pacha HM, et al
    Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jun 28. doi: 10.1002/ccd.28383.
    PubMed     Abstract available


  723. HIRAI T, Jacob D, Main ML, Grantham JA, et al
    A case of robotic assisted percutaneous coronary intervention of the left main coronary artery in a patient with very late baffle stenosis after surgical correction of anomalous left coronary artery from the pulmonary artery.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28382.
    PubMed     Abstract available


  724. SHAH R, Naz A
    Postprocedure bivalirudin infusion for primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 26. doi: 10.1002/ccd.28377.
    PubMed    


  725. CHANDIRAMANI R, Chen H, Aoi S, Giustino G, et al
    Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369.
    PubMed     Abstract available


  726. CHEN W, Lu D, Huang Z, Xiao L, et al
    Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2019 Jun 10. doi: 10.1002/ccd.28368.
    PubMed    


  727. TRIPATHI B, Yeh RW, Bavishi CP, Sardar P, et al
    Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28344.
    PubMed     Abstract available


  728. PRICE DJ, Levy MS
    CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone?
    Catheter Cardiovasc Interv. 2019;93:1253-1254.
    PubMed     Abstract available


    May 2019
  729. INOGUCHI Y, Kaku B, Kitagawa N, Katsuda S, et al
    Novel use of a stent graft for uncontrollable intraprocedural stent thrombosis in a patient with acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28346.
    PubMed     Abstract available


  730. MONTERO CABEZAS JM, Abou R, Goedemans L, Aguero J, et al
    Procedural-related coronary atrial branch occlusion during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and atrial arrhythmias at follow-up.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28351.
    PubMed     Abstract available


  731. KIM N, Lee JH, Jang SY, Bae MH, et al
    Intravascular modality-guided versus angiography-guided percutaneous coronary intervention in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 27. doi: 10.1002/ccd.28359.
    PubMed     Abstract available


  732. ZHANG J, Gao X, Ge Z, Han L, et al
    Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: Results from ULTIMATE trial.
    Catheter Cardiovasc Interv. 2019 May 22. doi: 10.1002/ccd.28308.
    PubMed     Abstract available


  733. CHEN Y, Yin T, Xi S, Zhang S, et al
    A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28325.
    PubMed     Abstract available


  734. BARBARAWI M, Kheiri B, Zayed Y, Barbarawi O, et al
    Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28280.
    PubMed     Abstract available


  735. DESCH S, Thiele H
    Letter commenting on: Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis (Kundu et al. Catheter Cardio
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28331.
    PubMed    


  736. KUNDU A, Sardar P, Kakouros N, Fisher DZ, et al
    Rebuttal: Response to letter by Desch et al. regarding "Outcomes of multivessel vs. culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-ana
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28334.
    PubMed    


  737. BAUER T, Zeymer U, Diallo A, Vicaut E, et al
    Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study.
    Catheter Cardiovasc Interv. 2019 May 8. doi: 10.1002/ccd.28318.
    PubMed     Abstract available


  738. SEKIGUCHI M, Muramatsu T, Kishi K, Muto M, et al
    Assessment of reattempted percutaneous coronary intervention strategy for chronic total occlusion after prior failed procedures: Analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28315.
    PubMed     Abstract available


    April 2019
  739. MOSCARELLA E, Ielasi A, Beneduce A, Ferrante G, et al
    One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28305.
    PubMed     Abstract available


  740. SEPPELT PC, Zappel J, Weiler H, Mas-Peiro S, et al
    Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28319.
    PubMed     Abstract available


  741. POZZI M, Flagiello M, Armoiry X, Generali T, et al
    Extracorporeal life support in the multidisciplinary management of cardiogenic shock complicating acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28316.
    PubMed     Abstract available


  742. TOVAR FORERO MN, van Zandvoort L, Masdjedi K, Diletti R, et al
    Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28304.
    PubMed     Abstract available


  743. ISHIKAWA M, Muramatsu T, Nanasato M, Nagasaka R, et al
    Associations of coronary plaque characteristics by integrated backscatter intravascular ultrasound with detectability of vessel external elastic lamina using optical frequency domain imaging in human coronary arteries: A sub-analysis of the MISTIC-1 t
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28218.
    PubMed     Abstract available


  744. VAN NUNEN LX, van 't Veer M, Zimmermann FM, Wijnbergen I, et al
    Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28289.
    PubMed     Abstract available


  745. TIJSSEN RYG, van der Schaaf RJ, Kraak RP, Vink MA, et al
    Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
    Catheter Cardiovasc Interv. 2019 Apr 9. doi: 10.1002/ccd.28193.
    PubMed     Abstract available


  746. KWOK CS, Sirker A, Farmer AD, Kontopantelis E, et al
    In-hospital gastrointestinal bleeding following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Apr 8. doi: 10.1002/ccd.28222.
    PubMed     Abstract available


    March 2019
  747. JIMENEZ-QUEVEDO P, Brugaletta S, Cequier A, Iniguez A, et al
    Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial.
    Catheter Cardiovasc Interv. 2019 Mar 20. doi: 10.1002/ccd.28194.
    PubMed     Abstract available


  748. BUTTER C, Okamoto M, Schymik G, Jacobshagen C, et al
    Degree of valve calcification in patients undergoing transfemoral transcatheter aortic valve implantation with and without balloon aortic valvuloplasty: Findings from the multicenter EASE-IT TF registry.
    Catheter Cardiovasc Interv. 2019 Mar 13. doi: 10.1002/ccd.28164.
    PubMed     Abstract available


  749. CRIMI G, Moramarco L, Mandurino-Mirizzi A, Quaretti P, et al
    The combined use of stent retriever and neuro-aspiration as successful bail-out reperfusion strategy in a patient with embolic myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Mar 9. doi: 10.1002/ccd.28167.
    PubMed     Abstract available


    February 2019
  750. ATTI V, Patel NJ, Kumar V, Tripathi B, et al
    Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161.
    PubMed     Abstract available


  751. AOI S, Htun WW, Freeo S, Lee S, et al
    Distal transradial artery access in the anatomical snuffbox for coronary angiography as an alternative access site for faster hemostasis.
    Catheter Cardiovasc Interv. 2019 Feb 24. doi: 10.1002/ccd.28155.
    PubMed     Abstract available


  752. YE Z, Lai Y, Yao Y, Mintz GS, et al
    Optical coherence tomography and intravascular ultrasound assessment of the anatomic size and wall thickness of a muscle bridge segment.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28094.
    PubMed     Abstract available


  753. RAMZY J, Andrianopoulos N, Roberts L, Duffy SJ, et al
    Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28145.
    PubMed     Abstract available


  754. WELCH TL, Law LA, Lanzino G, Lanier WL, et al
    Hydraulic stimulation of carotid artery baroreceptors as a likely cause of transient asystolic cardiac arrest during diagnostic angiography or surgical endarterectomy.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28126.
    PubMed     Abstract available


  755. FU Y, Gu XS, Hao GZ, Jiang YF, et al
    Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28112.
    PubMed     Abstract available


  756. IKEDA N, Kubota S, Okazaki T, Iijima R, et al
    The predictors of complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28133.
    PubMed     Abstract available


  757. TAKAYUKI G, Volker H, Axel H, Dirk F, et al
    Transfemoral transcatheter aortic valve implantation after aortic valve repair with HAART 300 device.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28129.
    PubMed     Abstract available


  758. WANG Y, Zhao HW, Wang CF, Fan CY, et al
    Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28087.
    PubMed     Abstract available


  759. LIGON RA, Petit CJ
    Working backward: Retrograde balloon angioplasty of atretic arteries in chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28115.
    PubMed     Abstract available


    January 2019
  760. RUBIMBURA V, Rostain L, Duval AM, Akakpo S, et al
    Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study.
    Catheter Cardiovasc Interv. 2019 Jan 31. doi: 10.1002/ccd.28084.
    PubMed     Abstract available


  761. WU K, Huang Z, Zhong Z, Liao H, et al
    Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28093.
    PubMed     Abstract available


  762. HE Y, Zhang D, Yin D, Zhu C, et al
    Development and validation of a risk scoring system based on baseline angiographic results by visual estimation for risk prEdiction of side-branch OccLusion in coronary bifurcation InterVEntion: The baseline V-RESOLVE score.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28068.
    PubMed     Abstract available


  763. HUANG X, Redfors B, Chen S, Gersh BJ, et al
    Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28096.
    PubMed     Abstract available


  764. REED GW, Rossi JE, Masri A, Griffin BP, et al
    Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28107.
    PubMed     Abstract available


  765. AL-HIJJI MA, Zack CJ, Nkomo VT, Pislaru SV, et al
    Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jan 27. doi: 10.1002/ccd.28074.
    PubMed     Abstract available


  766. NDREPEPA G, Cassese S, Hashorva D, Kufner S, et al
    Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28098.
    PubMed     Abstract available


  767. SHARMA SK, Bolduan RW, Patel MR, Martinsen BJ, et al
    Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28099.
    PubMed     Abstract available


  768. FAGGIONI M, Baber U, Chandrasekhar J, Sartori S, et al
    Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2019 Jan 17. doi: 10.1002/ccd.28033.
    PubMed     Abstract available


  769. JIA S, Zhao Y, Yang J, Zhao X, et al
    Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
    PubMed     Abstract available


  770. KHEIRI B, Abdalla A, Osman M, Barbarawi M, et al
    Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28075.
    PubMed     Abstract available


  771. POTTS J, Nagaraja V, Al Suwaidi J, Brugaletta S, et al
    The influence of Elixhauser comorbidity index on percutaneous coronary intervention outcomes.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28072.
    PubMed     Abstract available


  772. WANG H, Ning X, Zhu C, Yin D, et al
    Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28057.
    PubMed     Abstract available


  773. CHAN CY, Wu EB, Yan BP, Tsuchikane E, et al
    Procedure failure of chronic total occlusion percutaneous coronary intervention in an algorithm driven contemporary Asia-Pacific Chronic Total Occlusion Club (APCTO Club) multicenter registry.
    Catheter Cardiovasc Interv. 2019 Jan 3. doi: 10.1002/ccd.28064.
    PubMed     Abstract available


  774. AHN SG, Lee JW, Youn YJ, Lee SH, et al
    In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2019 Jan 2. doi: 10.1002/ccd.28032.
    PubMed     Abstract available


    December 2018
  775. CANNON LA, Kimmelstiel CD, White A, Hill R, et al
    Clinical outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
    Catheter Cardiovasc Interv. 2018 Dec 30. doi: 10.1002/ccd.28044.
    PubMed     Abstract available


  776. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
    Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
    PubMed     Abstract available


  777. LIU S, Song C, Zhao Y, Guan C, et al
    Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28030.
    PubMed     Abstract available


  778. FABRIS E, Ottervanger JP, Hermanides RS, Ten Berg JM, et al
    Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043.
    PubMed     Abstract available


  779. NEUPANE S, Khawaja O, Edla S, Singh H, et al
    Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28045.
    PubMed     Abstract available


  780. GAO G, Zhao Y, Zhang D, He Y, et al
    Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28053.
    PubMed     Abstract available


  781. IANNACCONE M, D'ascenzo F, Piazza F, De Benedictis M, et al
    Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28037.
    PubMed     Abstract available


  782. CORCOS T
    Distal radial access for coronary angiography and percutaneous coronary intervention: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Dec 11. doi: 10.1002/ccd.28016.
    PubMed     Abstract available


  783. ANDO T, Aoi S, Ashraf S, Villablanca PA, et al
    Transradial versus transfemoral percutaneous coronary intervention of left main disease: A systematic review and meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28025.
    PubMed     Abstract available


  784. FERNANDEZ-LOPEZ L, Chevalier B, Lefevre T, Spaziano M, et al
    Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28024.
    PubMed     Abstract available


  785. GOPALAKRISHNAN PP, Manoharan P, Shekhar C, Seto A, et al
    Redefining the fluoroscopic landmarks for common femoral arterial puncture during cardiac catheterization: Femoral angiogram and computed tomography angiogram (FACT) study of common femoral artery anatomy.
    Catheter Cardiovasc Interv. 2018 Dec 7. doi: 10.1002/ccd.27991.
    PubMed     Abstract available


  786. GUEDENEY P, Tchetche D, Petronio AS, Mehilli J, et al
    Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012.
    PubMed     Abstract available


    November 2018
  787. FINN MT, Doshi D, Cleman J, Song L, et al
    Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.27958.
    PubMed     Abstract available


  788. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
    PubMed     Abstract available


  789. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27986.
    PubMed     Abstract available


  790. JACOBZON E, Wolak A, Fink D, Silberman S, et al
    Delayed aortic dissection and valve thrombosis after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27994.
    PubMed     Abstract available


  791. SCHUMACHER SP, Driessen RS, Stuijfzand WJ, Raijmakers PG, et al
    Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non-occlusive lesions.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27945.
    PubMed     Abstract available


  792. GE J, Li J, Dong B, Ning X, et al
    Determinants of angiographic thrombus burden and impact of thrombus aspiration on outcome in young patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Nov 12. doi: 10.1002/ccd.27944.
    PubMed     Abstract available


  793. GURM HS, Mavromatis K, Bertolet B, Kereiakes DJ, et al
    Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert plus contrast reduction system.
    Catheter Cardiovasc Interv. 2018 Nov 4. doi: 10.1002/ccd.27935.
    PubMed     Abstract available


    October 2018
  794. USKELA S, Karkkainen JM, Eranen J, Siljander A, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950.
    PubMed     Abstract available


  795. THONGHONG T, Bieliauskas G, De Backer O, Sondergaard L, et al
    Economical cost of percutaneous vascular closure with ProGlide and Prostar XL following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27697.
    PubMed    


  796. WELT FGP, Klein LW, Tamis-Holland J, Blankenship J, et al
    Views of Appropriate Use Criteria for catheterization and percutaneous coronary revascularization by practicing interventional cardiologists: Results of a survey of American College of Cardiology Interventional Section members.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27931.
    PubMed     Abstract available


    September 2018
  797. DAVID SW, Khan ZA, Patel NC, Metzger DC, et al
    Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27905.
    PubMed     Abstract available


  798. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
    Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: